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Executive summary 
dŚŝƐƌĞƉŽƌƚƵƉĚĂƚĞƐƚŚĞĞŶƚƌĞĨŽƌ,ĞĂůƚŚĐŽŶŽŵŝĐƐ ?ƚŝŵĞ-series of National Health Service (NHS) 
productivity growth for the period 2015/16 to 2016/17 and reports trends in output, input and 
productivity since 2004/05. 
NHS productivity growth is measured by comparing the growth in outputs produced by the NHS to 
the growth in inputs used to produce them. NHS outputs include all the activities undertaken for 
NHS patients wherever they are treated in England, and also accounts for changes in the quality of 
care provided to those patients. NHS inputs include the number of doctors, nurses and support staff 
providing care, the equipment and clinical supplies used, and the facilities of hospitals and other 
premises where care is provided. 
NHS outputs have continuously increased since the start of this series in 2004/05. Over 5.2 million 
more hospital patients were treated as electives, day cases or emergency admissions in 2016/17 
than in 2004/05. This is equivalent to an increase of about 42%. Outpatient attendances have also 
increased, by approximately 131% since 2004/05, with over 60 million more contacts in 2016/17 
compared to 2007/08.1 In calculating productivity, adjustments are made for changes in quality of 
care. There have been year-on-year improvements in hospital survival rates whilst waiting times 
have been getting longer since 2009/10, although they remain shorter than they were in 2004/05. 
Taking account of these changes in the quality of care, overall quality adjusted NHS output has 
increased by 60% between 2004/05 and 2016/17, and by 3.51% between 2015/16 and 2016/17. 
Increases in NHS outputs have been mirrored by increases in inputs. Between 2004/05 and 2016/17, 
expenditure on NHS staff increased by 57.4%. In the same period, NHS expenditure on Agency staff 
has evolved quite erratically, with periods of increased use followed by periods of restraint. Overall 
Agency staff expenditure has increased by 88.5% since 2004/05, following the first year-on- year fall 
in expenditure since 2011/12. Expenditure on materials and capital increased by 202.3% and 189.2% 
respectively between 2004/05 and 2016/17. Altogether expenditure on NHS inputs increased by 
79.5% since 2004/05, and by 3% (in current terms) between 2015/16 and 2016/17. This equates to 
overall input growth in real terms, using the preferred direct measure of labour, of 0.64% between 
2015/16 and 2016/17. 
 
Over the last twelve years NHS productivity has increased by 16.52%. Productivity growth has been 
positive, with one exception, since 2009/10, with year-on-year growth averaging 1.30%. Productivity 
growth between 2015/16 and 2016/17 was 2.86%. 
  
                                                             
1 Outpatient activity data in 2004/05 are not directly comparable to Outpatient activity data in 2016/17. The classification 
system for Outpatient activity, as captured in the Reference Costs database, underwent a complete overhaul in 2006/07 as 
documented in Castelli et al. (2008)  
ii  CHE Research Paper 163 
Glossary of acronyms 
A&E Accident & Emergency 
APC Admitted Patient Care 
AD Admitted 
CCG Clinical Commissioning Group 
CHD Coronary Heart Disease 
CIPS Continuous Inpatient Spell 
CSU Commissioning Support Unit 
DH Department of Health 
ESR Electronic Staff Record 
EQ5D EuroQol five dimensions standardized instrument for measuring 
generic health status 
FCE Finished Consultant Episode 
FTE Full-time Equivalent 
GPPS GP Patient Survey 
H&SC Act Health & Social Care Act 2012 
HCHS Hospital and Community Health Services 
HES Hospital Episode Statistics 
HRG(4/4+) Healthcare Resource Group (version 4/4+) 
ISHP Independent Sector Health Care Provider 
MH Mental Health 
MSG Major Staff Group 
NAD Not admitted 
NHS National Health Service 
ONS Office for National Statistics 
PCA Prescription Cost Analysis 
PCT Primary Care Trust 
PROMs Patient Reported Outcome Measures 
PSSRU Personal & Social Services Research Unit 
QOF Quality and Outcomes Framework 
RC Reference Costs 
RDNA Regular Day and Night Attendance 
SHA Strategic Health Authority 
SUS Secondary Uses Service 
TFR Trust Financial Returns 
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1 Introduction 
This report ƵƉĚĂƚĞƐƚŚĞĞŶƚƌĞĨŽƌ,ĞĂůƚŚĐŽŶŽŵŝĐƐ ?ƚŝŵĞ-series of National Health Service (NHS) 
productivity growth. The full productivity series runs from 1998/99 (Bojke et al., 2016b), but this 
report updates the series to account for growth between 2015/16 and 2016/17, as well as looking at 
the 12 year trends starting from 2004/05. 
 
We follow national accounting conventions to measure the change in productivity over time by 
means of a chained index (Eurostat, 2001). We concentrate on the calculation and comparison of 
output and inputs between 2015/16 and 2016/17. dŚŝƐůĂƚĞƐƚ ‘ůŝŶŬ ?ŝƐƚŚĞŶĂƚƚĂĐŚĞĚƚŽƚŚĞĐŚĂŝŶĞĚ
index that reports productivity changes over the last decade. Appendix A reports the methodology 
followed in the construction of the output, input and productivity growth indices. 
 
NHS output growth between two financial years is calculated by means of a Laspeyres growth index, 
which aggregates different types of NHS output using the ƉƌĞǀŝŽƵƐǇĞĂƌ ?ƐĐŽƐƚĨŽƌĞĂĐŚƐƉĞĐŝĨŝĐ
output as weights. We adjust our output measure for quality, specifically taking account of changes 
in survival following hospital treatment, waiting times, and improvements in blood pressure 
monitoring in primary care. Improvements in these dimensions contribute to output growth. 
 
Growth in the volume of inputs is calculated primarily using expenditure data. Current spending on 
ůĂďŽƵƌ ?ĐĂƉŝƚĂůĂŶĚŵĂƚĞƌŝĂůƌĞƐŽƵƌĐĞƐĂƌĞĚĞĨůĂƚĞĚƚŽƚŚĞƉƌĞǀŝŽƵƐǇĞĂƌ ?ƐĐŽƐƚƐin order to facilitate a 
meaningful comparison of the volume of input use in the paired years. For labour we also use 
information about the volume and costs of staff recorded in the NHS Electronic Staff Record (ESR). 
This permits two alternative measures of input growth  W one constructed entirely from accounts 
data (the indirect measure) and one which uses expenditure data for capital and materials and ESR 
data for labour (the mixed measure of input growth). This allows us to assess how sensitive 
productivity growth is to how labour input is measured. 
 
The focus of the report is on the data used to calculate output and input growth between 2015/16 
and 2016/17. Specific details are provided about any potential data collection and coding artefacts 
that may compromise a genuine like-for-like comparison across these two years. 
 
The structure of the report is as follows. The output index is described in Section 2, and the elements 
of the input index are reported in Section 3. Section 4 reports the productivity growth figures. The 
summary and concluding remarks are provided in Section 5. 
  
2  CHE Research Paper 163 
2 Output 
 Measuring output 
Our NHS output index is designed to capture all activities provided to NHS patients, whether by NHS 
or private sector organisations.2  Table 1 below summarises data sources used to measure activity, 
quality and costs, and also indicates specific measurement issues that have had to be tackled in 
constructing the output growth index for 2015/16  W 2016/17. The data and these specific issues are 
detailed in the remainder of this section. It should be noted that we have two alternative sources of 
volume of activity for outpatient output: the Hospital Episode Statistics (HES) outpatient dataset, 
and the Reference Costs database. We compare the outpatient activity in these datasets. 
 
Table 1: Summary of output data sources 
Output type Activity source Cost source Quality Notes for 2015/16 and 
2016/17 data 
Elective HES RC 30-day/in- 
hospital survival; 
health outcomes 
waiting times 
Activity described by HRG4+. 
Since 2014/15 we have used 
in-hospital survival. 
Non-elective HES RC 30-day /in-
hospital survival; 
health outcomes 
Activity described by HRG4+. 
Since 2014/15 we have used 
in-hospital survival. 
Outpatient HES (or RC)  RC Waiting times Waiting time comes from HES. 
Two sources of activity data. 
Mental health HES & RC RC 30-day/in-hospital 
survival 
health outcomes 
waiting times 
Activity described by HRG4+. 
Since 2014/15 we have used 
in-hospital survival. 
Community 
care 
RC RC N/A  
A&E RC RC N/A  
Other (1) RC RC N/A  
Primary care QResearch (up 
to 2008/09); 
General 
Lifestyle Survey 
(2008/09-
09/10); 
GP patient 
survey (from 
2009/10) 
PSSRU Unit 
Costs of Health 
and Social Care 
QOF data Uplift survey responses by 
population growth; changes 
in QOF data. 
Prescribing Prescription 
cost analysis 
system 
Prescription 
cost analysis 
system 
N/A  
Ophthalmic 
and dental 
services 
NHS Digital NHS Digital N/A  
Note: (1) Radiotherapy & High Cost Drugs, Diagnostic Tests, Hospital/patient Transport Scheme, Radiology, 
Rehabilitation, Renal Dialysis, Specialist Services 
                                                             
2 NHS activity provided by non-NHS providers was included in the output growth series up to 2010/11. 
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 HES inpatient, day case, mental health and outpatient data 
HES is the source of data for both the amount of activity and for the measures of quality for elective 
and non-elective activity, including mental health care, delivered in hospitals.3 HES is comprised of 
20.6m records in 2015/16 and over 21.1m in 2016/17. We convert HES records, defined as Finished 
Consultant Episodes (FCEs), into Continuous Inpatient Spells (CIPS) using the official algorithm for 
calculating CIPS as published by NHS Digital (formerly the Health and Social Care Information 
Centre).4 We then count the number of CIPS in each Healthcare Resource Group (HRG), which form 
the basic means of describing different types of hospital output. In this report, we updated the code 
used to construct CIPS to reflect changes introduced by NHS Digital in the HES variable  ‘Admission 
Method (admimeth) ?.5 The old code only considered non-emergency transfers when determining 
CIPS, whilst the new code also takes into account emergency transfers from another hospital 
provider. The introduction of the new code for constructing CIPS has resulted in a reduction in the 
number of CIPS for the financial year 2015/16. 
 
The cost of each CIPS is calculated on the basis of the most expensive FCE within the CIPS, with costs 
for each HRG derived from the Reference Cost data (Bojke et al., 2013). Research by Daidone and 
Street (2011) suggests that results are not sensitive to alternative methods of calculating the costs of 
CIPS on the basis of the first episode or the sum of all episodes. Reference Costs are reported for 
each HRG according to their point of delivery, indicating whether the patient was treated as non-
elective inpatient, elective inpatient or elective day case (Department of Health, 2015). The non-
elective Reference Costs are used to determine the cost of patients treated on a non-elective basis, 
while we use the elective inpatient Reference Costs to determine the cost of all elective patients, 
including those treated on a day case basis (Bojke et al., 2016a). This ensures that elective inpatient 
and day-case activity is assigned the same cost weight and, hence, is assumed to be of equivalent 
value, despite the latter being of lower cost. This equal weighting ensures that the output index is 
not biased downwards if delivery of treatment moves to lower cost forms or settings over time. 
Having assigned a cost to each CIPS, we then calculate the national average cost per CIPS in each 
HRG.  
 
Changes to the HRG system pose some difficulties in constructing the output index because costs 
might not be available for newly recorded (retiring) activities. In such cases we deflate (inflate) costs 
in order to impute missing values (Castelli et al., 2011). Between the years 2015/16 and 2016/17, 87 
new HRGs were introduced, 35 were discontinued, 18 HRGs kept the same code but had a new 
description and 199 HRGs had a new code but the same description as existing HRGs.6   
 
 
 
                                                             
3 Consistently with previous publications of this series, we continue to exclude patients categorised to HRGs which are not 
included in the tariff ( ‘Zero Cost HRGs ?). 
4 http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=1072 (last access 07/02/2019) 
5 The vaƌŝĂďůĞ ‘admimeth ? ?ƚŚĂƚƐƉĞĐŝĨŝĞƐĂƉĂƚŝĞŶƚ ?ƐĂĚŵŝƐƐŝŽŶŵĞƚŚŽĚ ?ĐŚĂŶŐĞĚĨƌŽŵĂŶƵŵĞƌŝĐƚŽĂƐƚƌŝŶŐǀĂƌŝĂďůĞ ?ĂŶĚĂ
new form of admission, Transfer of an admitted patient from another Hospital Provider in an emergency (category 2B) is 
included now as a separate category. Previously, it was not possible to distinguish emergency admissions from another 
ŚŽƐƉŝƚĂůƉƌŽǀŝĚĞƌĨƌŽŵĂŶǇŽƚŚĞƌƚǇƉĞŽĨĂĚŵŝƐƐŝŽŶĂƐƚŚĞǇǁĞƌĞĂůůĐĂƉƚƵƌĞĚďǇƚŚĞŐĞŶĞƌŝĐĐĂƚĞŐŽƌǇ ‘KƚŚĞƌŵĞĂŶƐ ?ĐĂƚĞŐŽƌǇ
 ? ? ) ? ?ǁŚŝĐŚŝŶĐůƵĚĞĚĂůůƉĂƚŝĞŶƚs who arrive via the A&E department of another healthcare provider. 
6 Regarding the 18 HRGSs that kept the same code but had a new description: 14 belong to the subchapter  ‘GA ? 
 (Hepatobiliary and Pancreatic System Open Procedures), two to  ‘NZ ? (Obstetric Medicine) and the other two remaining to 
ƚŚĞƐƵďĐŚĂƉƚĞƌƐ ‘YR ? (Vascular Imagining Interventions) and  ‘SA ? (Haematological Procedures and Disorders), respectively. 
Regarding the HRGs with new code but with the same description: 111 belong to the subchapter  ‘FF ? (Digestive System Open 
and Laparoscopic Procedures), 34  ‘FE ? (Digestive System Endoscopic Procedures), 54  ‘FD ?(Digestive System Disorders). 
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The vast majority of activity captured in HES is performed by hospital Trusts. As shown in Table 2, 
just over 97% of all activity was performed in Trusts in both 2015/16 and 2016/17. The proportion of 
activity performed by private providers is gradually increasing: in 2012/13 they provided 2.1% of all 
activity, increasing to 2.7% in 2015/16 and to 2.8% in 2016/17. 
 
Table 2: Organisational coverage of HES activity, FCEs 
Year NHS Trusts Private providers Other7 Total 
2012/13 18,649,728 406,078 13,754 19,069,560 
2013/14 19,061,786 470,454 1,873 19,534,113 
2014/15 19,639,539 537,998 3,501 20,181,038 
2015/16 20,049,753 557,574 1,204 20,608,531 
2016/17 20,532,853 590,517 165 21,123,535 
 
2.2.1 Elective, day case and non-elective activity 
As can be seen from Table 3, elective and day case activity has increased by just over 57% over the 
12 year period covered in this report, from 6.4m to 10.1m CIPS, while non-elective activity has 
increased by about 26%, from 6m to 7.6m CIPS. While elective activity has grown steadily, growth in 
non-elective activity shows a more erratic pattern, as can be also observed in Figure 1. Between 
2015/16 and 2016/17 the number of elective CIPS increased by 241,194 CIPS (equivalent to a 2.4% 
increase), while non-elective activity increased by 129,208 CIPS (equivalent to a 1.7% increase). 
 
Table 3: Number of CIPS and average cost for electives and non-electives 
Year Elective and day case 
activity 
 
Non-elective activity 
 
# CIPS Average cost (£) # CIPS Average 
cost (£) 
2004/05 6,433,933 1,031 
 
6,009,802 1,210 
2005/06 6,864,612 1,041 
 
6,291,117 1,241 
2006/07 7,194,697 1,036 
 
6,363,388 1,244 
2007/08 7,598,796 1,091 
 
6,593,136 1,237 
2008/09 8,148,229 1,147 
 
6,826,035 1,354 
2009/10 8,465,757 1,227 
 
6,951,379 1,413 
2010/11 8,755,081 1,263 
 
7,109,358 1,460 
2011/12 8,946,909 1,287 
 
7,049,528 1,498 
2012/13 9,030,530 1,341 1,465* 7,327,228 1,532 
2013/14 9,336,918 1,373 1,501* 7,112,856 1,555 
2014/15 9,651,505 
 
1,523* 7,414,368 1,569 
2015/16 9,862,587 
 
1,590* 7,451,526 1,577 
2015/16** 9,862,566  1,590* 7,450,701 1,577 
2016/17** 10,103,760  1,569* 7,579,909 1,570 
Note: * In previous years we calculated the cost for elective and day case activity as a weighted average between cost of 
elective and day case activity, but since 2012/13 we switched to using elective costs only; ** Figures reflect the new CIPS 
methodology, following the changes in the HES variable  ‘admission method ?. 
                                                             
7 Primary Care Trusts (2012/13 only) and organisations with the org_code starting with 8 or A. 
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** Figures reflect the new CIPS methodŽůŽŐǇ ?ĨŽůůŽǁŝŶŐƚŚĞĐŚĂŶŐĞƐŝŶƚŚĞ,^ǀĂƌŝĂďůĞ ‘ĂĚŵŝƐƐŝŽŶŵĞƚŚŽĚ ? ? 
Figure 1: Changes in elective and day case and non-elective activity 
 
After cost-weighting this activity, we observe 2.45% growth in activity for electives and day cases 
and a growth of 3.98% for non-elective activity between 2015/16 and 2016/17. Combining both 
series, the total cost-weighted activity growth amounts to 3.10%. 
 
2.2.2 Elective, day case and non-elective activity: quality adjustment 
Our measure of hospital output captures growth in both the volume of activity and improvements in 
quality. The quality of hospital activity is measured by survival rate, estimated change in health 
outcomes following hospital treatment and mean life expectancy. Up to the financial year 2013/14, 
we used 30-day post discharge survival rate, but we have since switched to the in-hospital survival 
measure. This part of the quality adjustment is designed to capture changes in the expected 
discounted sum of lifetime Quality Adjusted Life Years (QALYs) conditional on patients surviving 
treatment. 
 
Our quality adjustment also accounts for changes in inpatient waiting times. Longer waiting times 
are considered to have adverse health consequences and formulated as a scaling factor multiplying 
the health effect (Castelli et al., 2007). This adjustment applies only to elective and day case activity, 
and is measured by 80th percentile waiting times. Information on in-hospital survival rate and waiting 
times is obtained directly from HES; 30-day survival post-discharge was calculated from the mortality 
dataset provided by ONS; mean life expectancy is taken from life tables published annually by ONS.8 
Table 4 and Figures 2-3 present average values for each of these measures over time. 
  
                                                             
6 http://www.ons.gov.uk/ons/rel/lifetables/national-life-tables/index.html (last accessed 07/02/2019)  
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7,000,000
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9,000,000
9,500,000
10,000,000
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Table 4: Quality adjustment for elective and day case and for non-elective activity 
Year  Elective and day case activity  Non-elective activity 
 
30-day 
survival 
rate 
In-hospital survival 
rate 
Mean life 
expectancy 
80th 
percentile 
waiting 
times 
30-day 
survival 
rate 
In-
hospital 
survival 
rate 
Mean life 
expectancy 
2004/05 99.38%  23.7 104 95.16%  34.1 
2005/06 99.47%  23.7 95 95.49%  34.3 
2006/07 99.51%  23.6 89 95.65%  34.6 
2007/08 99.72%  23.5 74 95.79%  34.7 
2008/09 99.74%  23.2 60 95.85%  34.4 
2009/10 99.76%  23.4 65 96.07%  34.6 
2010/11 99.78%  23.4 76 96.05%  34.8 
2011/12 99.45%  23.2 85 96.62%  34.6 
2012/13 99.50% 98.76% 23.2 82a 96.45% 97.77% 34.1 
2013/14a 99.44% 99.93% 23.2 81 96.32% 97.27% 34 
2014/15 - 99.93% 22.9 79 - 97.18% 33.4 
2015/16 - 99.93% 22.9 80 - 97.29% 33.5 
2016/17 - 99.94% 22.8 83 - 97.24% 33.3 
 a Previously reported figures showed the average across HRGs; from 2012/13 the figures show average across patients. 
 
Since April 2009, all providers of NHS-funded care have been required to collect Patient Reported 
Outcome Measures (PROMs) for all patients undergoing unilateral hip and knee replacement, 
varicose vein surgery and groin hernia repair. The PROMs survey includes the EQ-5D questionnaire, 
which allows responses to be scaled from perfect health (1) to death (0). Patients report their health 
status before and either three or six months after surgery. Table 5 reports the ratio of these before 
and after responses for those responding to both questionnaires for each condition since the 
questionnaire was first introduced. We use changes in the ratios to assess the impact that these four 
treatments have on ƉĂƚŝĞŶƚƐ ? health status over time. The smaller the ratio, the bigger is the health 
improvement associated with the treatment.  
 
Table 5: Ratio of pre to post health status, based on EQ-5D 
Year 
Groin 
hernia 
repair 
Hip 
replacement 
Knee 
replacement 
Varicose 
vein 
removal 
2009/10 0.82 0.32 0.37 0.84 
2010/11 0.8 0.36 0.41 0.82 
2011/12 0.8 0.4 0.4 0.71 
2012/13 0.76 0.36 0.37 0.8 
2013/14 0.84 0.37 0.39 0.8 
2014/15 0.82 0.37 0.44 0.85 
2015/16 0.79 0.36 0.4 0.77 
2016/17 0.86 0.39 0.46 0.73 
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For treatments where no such information is available, we assume that the ratio is 0.8 for elective 
care and 0.4 for non-elective care (Dawson et al., 2005). In this report, we also assign the above 
constant PROMs ratios to CIPS with error code UZ01Z. This follows from considerations that patients 
with a UZ01Z HRG code within the PROMs dataset are a very small and non-random sub-sample of 
all patients with a UZ01Z HRG code in the HES Inpatient dataset. Therefore, the average PROM ratios 
for UZ codes would be an unreliable estimate of the quality adjustment for all UZ codes in HES. For 
example, in the previous report that compared the financial years 2014/15  W 2015/16 the PROM 
ratios associated to UZ codes (0.339 and 0.313 respectively) were assigned to all UZ codes leading to 
a small overestimation of the overall quality adjusted hospital inpatient growth rates. See Table F2 in 
Appendix F for the corrected figures. 
 
There is little variation in mean life expectancy for those treated in hospital over the entire period, 
as shown in Figure 2. 
 
 
Figure 2: Mean life expectancy 
 
A slight negative trend can be observed in recent years: this is most likely due to increases in the 
average age of people admitted to hospital, rather than lower quality of care, given that hospital 
mortality rates have not declined. In particular, between 2015/16 and 2016/17 the mean life 
expectancy decreased by 0.1 and 0.2 years for electives and non-elective patients respectively. This, 
however, masks sometimes large variations in life expectancy at the HRG level.  
20
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In 2016/17 average waiting times increased by three days compared to 2015/16, as shown in Figure 
3. 
 
Figure 3: 80th percentile waiting times 
 
We calculate the quality adjustment for each specific HRG, and separately for electives and non-
electives. Once we take quality adjustment into account, the total Laspeyres output growth of 
elective, day case and non-elective activity is 3.66%. 
 
We find that the improvement in the quality adjusted output growth rate for hospital activity is 
driven by improvements in in-hospital survival rates and life-expectancy for non-elective activity.  
 
If considering elective and day cases separately from non-electives activity, we find that the quality-
adjusted growth rates between 2015/16 and 2016/17 are 2.41% and 5.32% respectively. There is a 
small deterioration in the quality for elective and day case activity that is driven by longer waiting 
times and shorter life expectancy of the patients treated (i.e. patients treated are on average older). 
Survival rates and PROMS show an improvement but do not compensate for the deterioration of the 
two other quality measures. On the other hand, the quality adjustment for non-elective activity is 
positive and substantial as both survival and life expectancy have improved.  
 
2.2.3 Inpatient mental health 
Until 2015/16 we identified mental health patients as those for which the HRG falls into the 
subchapter  ‘WD ? (Treatment of Mental Health Patients by Non-Mental Health Service Providers). 
There were three mental health HRGs in 2015/16, but in 2016/17 those three have been 
discontinued and split into 15 different HRGs (9 in the  ‘WD ? subchapter, 2 in the  ‘AA ? subchapter 
(Nervous system procedures and disorders) and 4 in the  ‘WH ? subchapter (Poisoning, Toxic Effects, 
Special Examinations, Screening and Other Healthcare Contacts)). In this case, we deflate current 
costs in order to impute prior values as previously stated.  
 
As seen in Table 6 and Figure 4, there has been year-on-year variation over the last decade in the 
number of patients with mental health problems treated in an elective/day case setting and a non-
elective setting, but numbers have decreased over the last four years. 
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Table 6: CIPS and average cost for inpatient mental health patients 
Year Elective and day case activity Non-elective activity 
 
# CIPS Average cost (£) # CIPS Average cost (£) 
2004/05 45,624 689 123,983 1,012 
2005/06 41,439 673 120,203 1,012 
2006/07 38,408 656 115,560 1,012 
2007/08 33,993 1,141 112,475 1,364 
2008/09 25,792 1,133 109,636 1,319 
2009/10 28,143 1,195 121,610 1,365 
2010/11 30,714 1,297 125,823 1,445 
2011/12 31,142 1,318 135,315 1,318 
2012/13 31,078 1,358 145,787 1,358 
2013/14 25,438 1,368 136,916 1,385 
2014/15 24,757 1,384 131,029 1,401 
2015/16 20,478 1,396 126,899 1,417 
2015/16** 20,483 1,396 126,867 1,417 
2016/17** 19,933 1,450 114,956 1,472 
Note:** Figures reflect the new CIPS methodology, following the changes in the HES variable  ‘admission method ?. 
 
 
 踃?&ŝŐƵƌĞƐƌĞĨůĞĐƚƚŚĞŶĞǁ/W^ŵĞƚŚŽĚŽůŽŐǇ ?ĨŽůůŽǁŝŶŐƚŚĞĐŚĂŶŐĞƐŝŶƚŚĞ,^ǀĂƌŝĂďůĞ ‘ĂĚŵŝƐƐŝŽŶŵĞƚŚŽĚ ? ? 
Figure 4: Number of CIPS for elective, day case and non-elective mental health patients over time 
 
After cost-weighting mental health activity, we observe an overall decline of -8.47% between 
2015/16 and 2016/17. The decline is more evident for non-elective activity than for elective, with 
cost-weighted growth rates equal to -9.39% and  ? 2.69%, respectively.  We conjecture that the 
negative growth observed in the last five years relates to the fact that we only account for mental 
health activity performed in non-mental health hospitals.  
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2.2.4 Inpatient mental health: quality adjustment 
As with other inpatient activity, we also account for changes in the quality of inpatient mental health 
care. We use the same quality adjusters as for other forms of inpatient activity, namely 30-day/in-
hospital survival rates, mean life expectancy and 80th percentile waiting times; these measures are 
reported in Table 7. 
 
Table 7: Quality adjustments for mental health activity 
Year  Elective and day case activity  Non-elective activity 
 
30-day 
survival rate 
In-hospital 
survival 
rate 
Mean life 
expectancy 
80th 
percentile 
waiting times 
30-day 
survival 
rate 
In-
hospital 
survival 
rate 
Mean life 
expectancy 
2004/05 97.72%  30.1 40 96.96%  28.7 
2005/06 98.01%  30.0 265 97.22%  28.9 
2006/07 98.15%  30.6 257 97.38%  29 
2007/08 98.64%  29.9 28 97.65%  27.7 
2008/09 98.71%  29.0 42 97.56%  27.3 
2009/10 98.61%  29.4 28 97.68%  27.7 
2010/11 98.85%  30.2 37 97.63%  27.8 
2011/12 98.83%  31.1 37 97.78%  27.3 
2012/13 98.41% 99.91% 29.6 52a 97.61% 97.29% 26.9 
2013/14a 98.72% 98.95% 30.6 54 97.52% 97.87% 27.4 
2014/15b - 99.25% 31.3 51 - 98.66% 27.1 
2015/16 - 99.38% 31.6 54 - 98.63% 26.9 
2016/17 - 98.91% 30.3 59 - 98.04% 25.1 
a Previously reported figures showed the average across HRGs; from 2012/13 the figures show the average across patients. 
b Previously, the in-hospital survival rates for elective and non-elective patients were estimated to be 99.1% and 98.25% 
respectively (Bojke et al., 2017). 
 
In the same way as for other HES inpatient activity, we also calculate quality adjustment based on 
the performance in a specific HRG (separated for electives and non-electives). On average, all the 
quality measures have deteriorated with respect to 2015/16: MH patients show lower in-hospital 
survival rates, lower mean life expectancy and wait longer for treatments. Hence, once we take 
quality adjustment into account, output growth from 2015/16 to 2016/17 decreases from -8.47% 
to -9.32% for Mental Health provided to patients admitted to hospital. 
 
2.2.5 HES outpatient activity 
Outpatient activity can be derived from both the HES Outpatients Dataset and the RC data. In this 
section we present summary statistics for outpatient activity derived from the HES Outpatient 
dataset. This dataset does not include unit cost information, which we derive from the RC data. A 
like-for-like comparison between the two datasets is not wholly possible because the activity data 
are recorded somewhat differently in each. Specifically, the HES Outpatient dataset does not allow 
classification of activity into consultant-led and non-consultant led activity, which is the common 
definitional split for non-procedural activity in RC. For a successful match, one would need 
consultant codes in HES, which are considered sensitive and were not available to us. The HES 
outpatient activity classification is a combination of treatment speciality and SUS HRG code. 
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A further difference between HES and RC recorded activity is that HES covers activity conducted by 
organisation types other than Trusts. In addition, HES contains data on appointments which were 
attended and those which were not. Only attended appointments, representing approximately 80% 
of recorded data, are included in the RC series.  
 
For the purpose of attaching unit cost data to HES outpatient activity, we match consultant-led and 
non-consultant-led activity definitions from Reference Costs to those in HES, weighted averages are 
taken to produce averages specific only to currency codes (e.g. WF01A) and service codes. These 
averages are matched to HES activity. An initial round of matching was based on a complete match 
of Reference Cost service code and currency code combination with HES treatment speciality and 
SUS HRG code. This led to over 95% of records being matched to an associated RC code, the 
remaining unmatched records are assigned an overall average cost. 
 
Table 8: Volume and average cost over time 
Year All providers (excl. ISHP and 
 ?KƚŚĞƌƉƌŽǀŝĚĞƌƐ ? ?
 
Volume Average cost 
(£) 
2011/12 88,926,968 114 
2012/13 90,850,009 116.98 
2013/14 96,690,559 117.18 
2014/15 101,382,540 118.26 
2015/16 107,092,657 118.37 
2016/17 112,038,760 121.74 
 
Table 8 shows the volume and average cost of attended outpatient activity. After cost weighting the 
activity, the Laspeyres growth in outpatient activity amounts to 5.37%. 
  
12  CHE Research Paper 163 
2.2.6 HES outpatient activity: quality adjustment 
We allow for changes in the quality of outpatient activity by taking account of changes in waiting 
times, as summarised in Table 9 and Figure 5.  
 
The 80th percentile waiting time has increased over the years and reached a maximum of 68 days 
in 2016/17. However, accounting for this has virtually no impact on the growth index which drops 
slightly to 5.34%. 
 
Table 9: Outpatient mean and 80th percentile waiting times (days) 
Year DH HES HES 
 
Mean 80th 
Percentile 
2004/05 52 
  
2005/06 46 
  
2006/07 41 
  
2007/08 24 37 
 
2008/09 22 34 
 
2009/10 24 36 
 
2010/11 
 
37 
 
2011/12 
 
37 
 
2012/13 
 
38 55 
2013/14 
 
40 57 
2014/15 
 
42 61 
2015/16 
 
44 63 
2016/17  48 68 
 
 
 
Figure 5: Trends in outpatient waiting times 
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 Reference cost data 
Reference Cost (RC) returns are used to capture activity performed in most health care settings 
other than hospitals, outpatient departments and primary care. In particular, RC data cover activity 
conducted in accident and emergency (A&E) departments, mental health and community care 
settings, and diagnostic facilities. Activities are reported in various ways: attendances, bed days, 
contacts and number of tests. 
 
 RC returns, in their main schedule, only cover activity undertaken by hospital Trusts, but since 
2014/15 RC returns have also been submitted for contracted-out activity, that is activity delivered by 
independent sector (non-NHS) providers. Activity provided by non-NHS providers is not included in 
the overall NHS output growth measure. However, we have conducted a sensitivity analysis of both 
outputs and inputs provided by non-NHS providers, the results of which are presented in Appendix 
B. 
 
RC returns also provide information on unit costs for all recorded activities (and about the costs of 
activity performed in hospitals and outpatient departments, as previously mentioned). 
 
Reference Costs data are checked for both the accuracy of the reported data and the activity 
coverage. 
 
2.3.1 General RC data validation checks 
Since 2011/12, the Department of Health has required mandatory and non-mandatory validations of 
the Reference Cost data reported by NHS Trusts (Department of Health, 2012). These have reduced 
the year-on-year volatility in the information contained in the RC returns. These validations, both 
mandatory and non, are carried out also by NHS Improvement, which has been commissioned to 
collect and report Reference Cost data since 2014/15, see Castelli et al. (2018). 
Over and above these checks, we have implemented our own validation process (Bojke et al., 2014). 
This focuses on identifying large increases/decreases in either volume or unit costs of activity for all 
non-acute services. Since 2015/16, we have revised our quality and assurance process, which now 
consists of four steps. 
In step 1, we check whether a large change in either the total volume (>500,000 units) or the total 
value (>£25,000,000) of NHS activity/HRG codes as reported in the Reference Cost returns can be 
detected. The check compares volumes of activity, unit costs and total costs of the last two financial 
years in the national productivity series.  
In step 2, we identify cases of NHS activity/HRG codes that do not appear to be genuine. This step 
might require further investigation and may lead to the identification of a sub-set of HRG/service 
codes related to the NHS activity/HRG codes flagged as not being genuine changes. 
Limited to the HRG/service codes that have been identified as requiring further investigation, two 
further steps are followed, when applicable: 
In step 3, we check whether any of the flagged HRG/service codes are affected by changes in their 
labelling/definition/categorisation. This step involves cross-checking the set of HRGs with potential 
quality issues against the HRG codes listed in the HRG4+ Reference Costs Grouper Roots file 
(content.digital.nhs.uk/casemix/costing). If this is not the case, then in step 4, we analyse the data in 
greater detail to identify the source of the large change in either volume or value of activity. 
The current quality check compared the Reference Cost data for the financial years 2015/16 and 
2016/17. It identified 17 types of activity/HRG codes, pertaining to three different NHS settings,  
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with a large change in the total volume of the activity and nine types of activity/HRG codes, 
pertaining to four different NHS settings, with a large change in the total volume of activity reported. 
Table 10 and Table 11 list NHS activity/HRG codes with a large change in volumes and a large 
changes in values respectively, as well as summary statistics. 
 
Further in-depth investigation in these NHS activity/HRG codes did not identify any inaccuracies with 
the data reported in the Reference Costs returns and no further action/adjustments were deemed 
necessary for the 2016/17 update. 
 
Table 12 summarises the RC data according to broad service settings over the past two years. This 
shows that the number of categories is quite stable between 2015/16 and 2016/17 across the 
different settings. 
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Table 10: Large changes in Volumes of Activity, 2015/16  ? 2016/17 
NHS setting Service/HRG code 2016/17 2015/16 Diff in Volume 
 
(a)  ? (c) 
 
Activity 
(a) 
Unit Cost (£) 
(b) 
Activity 
(c) 
Unit Cost (£) 
(d) 
Community Care N02AF 30,371,780 £37 28,905,584 £38 1,466,196  
Community Care N03F 4,115,184 £55 4,666,923 £53 -551,739  
Community Mental Health MHCC99 25,563,335 £8 20,128,996 £8 5,434,339  
Community Mental Health MHCC07 17,774,673 £9 16,868,894 £10 905,779  
Community Mental Health MHCC05 10,068,969 £12 9,440,495 £12 628,474  
Community Mental Health MHCC12 17,990,955 £12 18,584,390 £11 -593,435  
Community Mental Health MHCC11 21,444,287 £8 22,068,752 £8 -624,465  
Community Mental Health MHCC20 8,953,402 £6 9,617,603 £6 -664,201  
Community Mental Health MHCC04 18,661,725 £8 19,979,242 £9 -1,317,517  
Community Mental Health MHCC03 10,388,165 £7 12,162,886 £7 -1,774,721  
Community Mental Health MHCC19 26,347,133 £5 28,345,991 £5 -1,998,858  
Community Mental Health MHCC18 28,136,002 £4 30,976,717 £4 -2,840,715  
Diagnostic tests DAPS04 246,468,097 £1 234,557,502 £1 11,910,595  
Diagnostic tests DAPS07 21,877,751 £8 20,700,717 £8 1,177,034  
Diagnostic tests DAPS05 43,200,087 £3 42,045,618 £3 1,154,469  
Diagnostic tests DAPS09 6,382,090 £3 5,250,509 £3 1,131,581  
Diagnostic tests DAPS03 44,093,504 £2 44,881,533 £2 -788,029  
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Table 11: Large change in the value of activity, 2015/16  ? 2016/17 
NHS Setting Service / 
HRDG code 
2016/17 2015/16 Total value of 
2016/17 activity 
 in 2016/17 costs 
(£) 
Total value of 
2016/17 activity  
in 2015/16 costs 
(£) 
Diff in Value 
  Activity 
(a) 
Unit Cost (£) 
(b) 
Activity 
(c) 
Unit Cost (£) 
(d) 
(e) (f) (f)  W (e) 
A&E  ASS02 5,277,120 £247 5,167,876 £236 £1,306,086,176 £1,247,724,034 -£58,362,142 
A&E  VB08Z 2,869,564 £171 2,869,320 £157 £490,504,392 £449,649,020 -£40,855,372 
A&E  VB11Z 1,807,819 £105 1,860,471 £91 £190,577,369 £164,094,912 -£26,482,457 
Chemo/Radiotherapy &  
High Cost Drugs 
XD31Z 166,884 £1,115 162,902 £1,392 £186,105,472 £232,325,710 £46,220,237 
Chemo/Radiotherapy &  
High Cost Drugs 
XD21Z 45,202 £439 7,982 £1,592 £19,824,446 £71,955,020 £52,130,574 
Community Care N03G 3,406,977 £75 3,712,433 £65 £255,756,466 £220,790,083 -£34,966,383 
Community Care N02AF 30,371,780 £37 28,905,584 £38 £1,121,525,866 £1,153,429,067 £31,903,201 
Community Care IC02 1,272,790 £288 945,767 £314 £367,195,260 £399,472,759 £32,277,499 
Community Mental Health CAMHSCC 1,882,991 £221 1,520,145 £242 £416,434,665 £456,399,199 £39,964,534 
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Table 12: Reference cost settings 
Setting 2015/16 2016/17 
  Nr Cat. Activity Cost (£) Nr Cat. Activity Cost (£) 
A&E and Ambulance Services 92 37,792,911 4,454,964,482 93 38,758,786 4,818,530,379 
Chemo/Radiotherapy & High Cost Drugs 340 6,283,287 3,697,193,821 342 6,789,735 4,824,078,484 
Community Care 184 86,767,072 5,171,028,803 176 87,751,894 5,329,232,493 
Diagnostic Tests 81 367,378,910 984,870,571 84 382,697,201 1,010,246,713 
Community Mental Health 156 253,346,232 354,670,482 157 250,019,639 5,989,209,182 
Outpatient 9,616 85,394,479 10,221,877,406 9,627 87,017,943 10,631,641,076 
Radiology 267 10,755,438 1,048,586,605 263 11,342,904 1,074,705,162 
Rehabilitation 99 2,985,717 990,145,041 96 2,893,451 959,182,247 
Renal Dialysis 37 4,157,008 556,027,298 38 4,240,850 567,754,893 
Specialist Services 143 5,162,337 3,402,452,724 146 5,426,763 3,456,507,951 
Other 1,130 3,990,126 319,906,305 1,135 3,886,440 298,967,522 
Note: A Table summarising the RC data according to broad service settings for the years 2012/13 - 2015/16 can be found in Appendix C. 
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2.3.2 RC outpatient activity 
Outpatient activity as measured in the RC database is classified into three major groups: consultant 
led activity; non-consultant led activity; and procedures. Consultant and non-consultant led activity 
represent broadly the same set of outpatient specific HRG-style codes (currency codes beginning 
with WF) and outpatient procedure codes represent procedure-related HRGs which may appear in 
other hospital settings. Consultant led activity for Trusts represents about 60% of overall outpatient 
activity, non-consultant led just under 25%, whilst outpatient procedures are just under 15% of 
overall outpatient activity, increasing considerably, since 2007/08 when their share was about 3%. 
 
Table 13: Outpatient activity and cost 
Year Outpatient 
 
All providers Trusts only 
 
Volume of activity Average cost 
(£) 
Volume of activity Average cost 
(£) 
2007/08 69,679,600 94 61,508,362 98 
2008/09 74,421,017 98 65,804,814 103 
2009/10 80,093,906 101 71,115,142 105 
2010/11 81,301,615 105 73,621,984 107 
2011/12 - - 75,826,947 108 
2012/13 - - 77,222,725 111 
2013/14 - - 81,699,802 114 
2014/15 - - 83,856,229 117 
2015/16 - - 85,394,479 120 
2016/17   87,017,943 122 
 
The Laspeyres output growth measure for outpatient activity, as captured by the Reference Costs 
data, is 2.7% for financial years 2015/16 and 2016/17.  
 
The difference between HES and RC measures of outpatient activity growth is about 2.64%, with RC 
data reporting lower growth than the HES outpatient data. Although both datasets have some 
quality issues, our preferred method uses HES, as it is a patient-level dataset as opposed to the more 
aggregated RC. This allows us to perform more thorough quality checks and better assure a like-for-
like comparison over time. 
 
2.3.3 A&E and ambulance services 
Table 14 reports summary statistics for A&E services provided in Emergency Departments (EDs) and 
Other A&E services according to whether patients were subsequently admitted to hospital (AD) or 
not admitted (NAD).  
 
Emergency departments offer a consultant-led 24 hour service with full resuscitation facilities and 
designated accommodation for the reception of A&E patients.9 Between 2015/16 and 2016/17, the 
total number of emergency department attendances declined slightly by 0.1%, with a decrease of 
                                                             
9 https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics/hospital-
episode-statistics-data-dictionary, p.15(last accessed 12/03/2019) 
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about 3.3% in the number of people being subsequently admitted to hospital. EDs attendances not 
leading to admitted hospital stay increased by just under 1.1% between 2015/16 and 2016/17. 
The cateŐŽƌǇ ‘KƚŚĞƌ ?ƐĞƌǀŝĐĞƐ ?ĐĂƉƚƵƌĞƐĂĐƚŝǀŝƚŝĞƐĐĂƌƌŝĞĚŽƵƚŝŶĂŶǇŽĨƚŚĞĨŽůlowing 
ĚĞƉĂƌƚŵĞŶƚƐ P ‘ŽŶƐƵůƚĂŶƚ-led mono specialty accident and emergency services (e.g. ophthalmology, 
ĚĞŶƚĂů )ǁŝƚŚĚĞƐŝŐŶĂƚĞĚĂĐĐŽŵŵŽĚĂƚŝŽŶĨŽƌƚŚĞƌĞĐĞƉƚŝŽŶŽĨƉĂƚŝĞŶƚƐ ? ? ‘KƚŚĞƌtype of A&E/minor 
injury activity with designated accommodation for the reception of accident and emergency 
ƉĂƚŝĞŶƚƐ ?ĂŶĚ ‘E,^tĂůŬ-in ĞŶƚƌĞƐ ? ? ‘KƚŚĞƌ ?ƐĞƌǀŝĐĞƐ ?ŝŶĐƌĞĂƐĞĚŽǀĞƌĂůůďǇ6.7% between 
2015/16 and 2016/17, with patients being subsequently admitted to hospital decreasing by 0.2%. 
Overall, the total volume of A&E activity increased by 1.5% between 2015/16 and 2016/17. 
However, the number of patients subsequently being admitted to hospital as emergency cases, 
decreased between 2015/16 and 2016/17. This continues a similar pattern observed between 
2014/15 and 2015/16. We think that it might be an indication of people presenting at A&E 
departments (of all types) with ambulatory care conditions, which should have been attended to in a 
primary care setting. 
Table 14: A&E activity and average cost 
Year Emergency departments Other A&E services 
 
AD NAD AD NAD 
 
Volume of 
activity 
Average 
cost 
(£) 
Volume of 
activity 
Average 
cost 
(£) 
Volume of 
activity 
Average 
cost 
(£) 
Volume of 
activity 
Average 
cost 
(£) 
2006/07 3,464,869 107 10,327,147 83 281,135 50 3,900,718 36 
2007/08 3,326,719 121 9,058,765 89 531,498 70 3,769,765 43 
2008/09 3,566,642 118 9,708,958 99 1,000,986 49 4,184,796 49 
2009/10 4,047,176 134 10,075,701 103 1,090,650 49 3,628,469 50 
2010/11 4,004,868 141 9,881,747 108 1,145,125 62 3,800,261 55 
2011/12 4,040,760 157 10,405,762 108 616,812 83 3,253,452 52 
2012/13 4,345,100 160 10,292,933 115 362,656 90 3,426,231 59 
2013/14 4,218,480 177 10,189,225 127 494,549 80 3,639,355 59 
2014/15 4,050,701 206 10,636,666 133 446,779 65 3,972,875 61 
2015/16 4,101,720 219 10,921,696 140 473,723 69 4,202,986 60 
2016/17 3,966,820 238 11,039,457 152 472,913 78 4,515,570 67 
Legend: AD  W leading to admitted patient care; NAD  W Not leading to admitted patient care 
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Figure 6: Trend of A&E activity across settings 
 
Ambulance services are reported in Table 15 for the four years since this type of NHS activity was 
first recorded in the Reference Cost database. Activity is measured in terms of calls received for the 
ĐĂƚĞŐŽƌǇ ‘ĂůůƐ ? ?ƉĂƚŝĞŶƚƐĨŽƌƚŚĞĐĂƚĞŐŽƌǇ ‘,ĞĂƌĂŶĚƚƌĞĂƚŽƌƌĞĨĞƌ ? ?ŝŶĐŝĚĞŶƚs for both ĐĂƚĞŐŽƌŝĞƐ ‘^ĞĞ
ĂŶĚƚƌĞĂƚŽƌƌĞĨĞƌ ? ‘^ĞĞĂŶĚƚƌĞĂƚĂŶĚĐŽŶǀĞǇ ? ?KǀĞƌĂůůĂĐƚŝǀŝƚǇďǇĂŵďƵůĂŶĐĞƐĞƌǀŝĐĞƐcontinued to 
increase between 2015/16 and 2016/17 with a growth rate of 3.71%.  
Table 15: Ambulance services 
Year Ambulance services 
 
Calls Hear and treat or 
refer 
See and treat or 
 refer 
See and treat and 
convey 
 
Volume of 
activity 
Average 
cost 
(£) 
Volume 
of 
activity 
Average 
cost 
(£) 
Volume 
of activity 
Average 
cost 
(£) 
Volume 
of activity 
Average 
cost 
(£) 
2011/12 8,530,563 8 338,022 44 1,862,892 173 4,895,376 230 
2012/13 9,120,422 7 423,821 47 1,997,327 174 4,984,296 230 
2013/14 8,926,215 7 400,005 44 2,113,757 180 5,069,806 231 
2014/15 9,491,159 7 575,168 35 2,270,229 180 5,107,902 233 
2015/16 9,794,437 7 782,665 34 2,347,808 181 5,167,876 236 
2016/17 10,238,451 7 806,804 37 2,441,651 181 5,277,120 247 
 
dŚĞ>ĂƐƉĞǇƌĞƐŽƵƚƉƵƚŐƌŽǁƚŚŵĞĂƐƵƌĞĨŽƌƚŚĞƐĞƚƚŝŶŐ ? ?ƐĞƌǀŝĐĞƐ ? ?ǁŚŝĐŚŝŶĐůƵĚĞƐĂŵďƵůĂŶĐĞ
services, increased by 2.2% between 2015/16 and 2016/17.
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2.3.4 Chemotherapy, Radiotherapy & High Cost Drugs 
The categories used to describe Chemotherapy, Radiotherapy, and High Cost Drugs have been 
subject to substantial revisions over time, making it difficult to infer much from the simple counts of 
activity reported below in Table 16 and Figure 7. However since 2013/14 categorisation has been 
fairly stable for all three types of activity. High Cost Drugs had three new category added in 2016/17, 
whilst Radiotherapy has one less category in 2016/17 and Chemotherapy had no categorisation 
changes. Contrary to growth rates found between 2014/15 and 2015/16, in the most recent link, 
only High Cost Drugs recorded an increase in the raw volume of activity between 2015/16 and 
2016/17 of about 8.2%, whilst both Chemotherapy and Radiotherapy recorded a decrease in the 
total volume of activity of respectively 22.7% and 4.43%. It is worth noting, however, that the 
average cost of Chemotherapy activity increased by 33% between 2015/16 and 2016/17. 
 
Overall, however, the Laspeyres output growth measure for Chemotherapy, Radiotherapy & High 
Cost Drugs increased by 8.4% between 2015/16 and 2016/17.  
 
Table 16: Chemotherapy, Radiotherapy, High Cost Drugs 
Year Chemotherapy Radiotherapy High Cost Drugs 
 
Volume of 
activity 
Average 
cost 
(£) 
Volume of 
activity 
Average 
cost 
(£) 
Volume of 
activity 
Average 
cost 
(£) 
2004/05 777,312 363 1,622,278 113 - - 
2005/06 763,806 432 1,634,156 126 - - 
2006/07 1,642,444 280 1,743,490 123 26,277,491 17 
2007/08 846,425 406 1,613,135 559 1,332,996 305 
2008/09 1,428,561 448 1,710,525 157 1,322,354 473 
2009/10 1,414,872 505 1,835,695 163 2,412,988 384 
2010/11 1,515,845 515 2,001,798 161 1,288,460 818 
2011/12 1,769,727 505 2,492,431 137 1,372,131 902 
2012/13 2,525,935 387 2,717,024 127 1,511,644 878 
2013/14 2,540,353 431 2,760,237 134 1,687,711 859 
2014/15 2,729,954 449 2,855,371 135 1,982,162 877 
2015/16 2,913,719 454 2,018,956 188 2,115,966 942 
2016/17 2,253,067 605 1,929,548 198 2,288,895 917 
Note: In 2006/07, High Cost Drugs were recorded as number of procurements, after which recording was by number of 
patients.
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In 2006/07, High Cost Drugs were categorised and costed differently to subsequent years, hence 
this data point has not been included in the Figure. 
Figure 7: Laspeyres output growth for Chemotherapy, Radiotherapy and High Cost Drugs over time 
 
2.3.5 Community care 
Table 17 reports total volumes of Community Care activity from 2004/05 to 2016/17. With the 
dismantlement of Primary Care Trusts (and Personal Medical Services Pilots) in 2011/12, Community 
Care experienced a big drop in its recorded and reported activity for a number of years. However, 
we note that from 2013/14 reported activity has continuously increased. Between 2015/16 and 
2016/17 Community care activity increased by 1.14%, with an associated Laspeyres output growth 
index of 2.3%. 
Table 17: Community care activity 
Year Community care 
 
Volume of activity (a) Average cost (£) 
2004/05 75,673,792 39 
2005/06 85,092,838 38 
2006/07 83,895,139 40 
2007/08 85,470,688 42 
2008/09 88,513,663 45 
2009/10 92,412,727 46 
2010/11 90,724,524 47 
2011/12 78,315,576 50 
2012/13 79,709,044 52 
2013/14 85,975,592 57 
2014/15 85,733,534 59 
2015/16 86,767,072 60 
2016/17 87,751,894 61 
Note: In 2011/12, PCTs and PMS ceased to report activity about community care. Total volume of 
activity from 2011/12 is, therefore, not comparable with previous years. 
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2.3.6 Diagnostic tests, pathology and radiology 
In 2014/15, Nuclear Medicine (included in the Radiology setting), underwent a complete re-
categorisation exercise, increasing the level of granularity in the reporting of activity, with the total 
number of categories growing from 7 in 2013/14 to 139 in 2016/17. 
 
Table 18: Directly accessed diagnostic and pathology services and radiology 
Year 
Directly accessed 
diagnostic services 
Directly accessed pathology 
services 
Radiology 
 
Volume of 
activity 
Average 
cost (£) 
Volume of activity 
Average 
cost (£) 
Volume of activity 
Average 
cost (£) 
2004/05 369,988 44 180,676,234 3 5,152,720 31 
2005/06 465,622 44 221,966,384 2 5,784,605 33 
2006/07 735,569 137 236,269,050 2 23,918,500 59 
2007/08 776,368 41 257,249,379 2 7,614,437 103 
2008/09 804,607 46 278,917,852 2 7,852,498 102 
2009/10 1,063,744 43 300,010,031 2 8,347,404 104 
2010/11 1,458,025 39 320,418,662 2 8,491,834 97 
2011/12 5,640,762 34 333,108,317 2 8,758,136 93 
2012/13 6,339,016 30 335,941,593 2 9,381,616 92 
2013/14 6,553,727 31 361,952,265 2 9,709,456 93 
2014/15 7,128,172 32 356,528,477 2 9,440,280 88 
2015/16 7,467,097 31 359,911,813 2 10,755,438 97 
2016/17 7,849,470 32 374,847,731 2 11,342,904 95 
Note: In 2004/05 and 2005/06, radiology was recorded as number of tests; in 2006/7 it comprised number of tests and 
interventions; from 2007/08 it was number of patients. 
 
The total volume of Directly Accessed Diagnostics services, Directly Accessed Pathology services and 
Radiology all increased between 2015/16 and 2016/17, respectively by 5.1%, 4.1% and 5.46%. The 
Laspeyres output growth for each broad type of test was 5.6%, 3.8% and 6.8% respectively, 
leading to an overall growth for these combined activities of 5.5%. 
 
2.3.7 Community mental health 
Table 19 summarises overall counts of Community Mental Health activity since 2004/05. Activity in 
this setting underwent a major revision in 2011/12 with the creation of mental health clusters but 
has since appeared to settle into a consistent measurement scheme.   
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Table 19: Community mental health 
Year Community mental health 
 
Volume of 
activity 
Volume of 
activity (a) 
Average 
cost (£) 
2004/05 16,389,891 
 
164 
2005/06 17,738,894 
 
170 
2006/07 19,259,205 
 
167 
2007/08 21,751,043 
 
153 
2008/09 22,674,811 
 
157 
2009/10 23,440,616 
 
161 
2010/11 24,341,950 
 
159 
2011/12 
 
224,329,080 28 
2012/13 
 
260,266,214 24 
2013/14 
 
259,659,214 25 
2014/15 
 
262,460,243 25 
2015/16 
 
253,275,018 26 
2016/17  250,019,639 24 
Note: Due to the reclassification of activity in Community Mental Health, data from 2011/12 are not directly comparable 
with data reported in previous years. Hence, Community mental health activity was excluded from the calculations of both 
the Community Mental Health and the overall NHS output growth indices for the pair of years 2010/11 to 2011/12.  
 
In 2015/16 the Reference Costs data added to its collection activity and cost information for 
 ‘Improving Access to Psychological Therapy (IAPT) ? activity for adults by clusters. In previous years, 
this activity, although not of comparable nature, was captured by contact and delivered by the 
Mental Health Specialist teams. As a consequence, we had to exclude the newly reported IAPT 
activity and that reported under MH specialist teams respectively for the years 2015/16 and 2014/15. 
In 2016/17 activity and cost information for IAPT activity continued to be reported in a comparable 
manner to 2015/16 and hence, we have included this type of Community Mental Health activity in 
our output growth measure.  
 
However, we have to report three separate tables summarising Community Mental Health activity: 
one for the years from 2011/12 to 2014/15, one for the financial years 2014/15 and 2015/16, for 
which we had to exclude IAPT activity, and finally one for 2015/16 and 2016/17. However, an 
adjustment had to be made to the Mental Health data as the accompanying report to the 2016/17 
Reference Cost data states on p. 7 that  ‘the methodology for collecting some secure services data was 
changed to a combination of pathway and cluster; it is no longer viable to compare unit costs across 
years ?. All secure mental health services have been excluded from the calculation of the Community 
Mental Health output growth measure for the years 2015/16 and 2016/17.  
 
Note that  ‘Other Mental Health ? activity underwent a re-labelling of broad category exercise back in 
2014/15, which has since continued. Thus, in Table 20 ƚŚĞĐĂƚĞŐŽƌŝĞƐƌĞƉŽƌƚĞĚƵŶĚĞƌ ‘KƚŚĞƌDĞŶƚĂů
,ĞĂůƚŚ ?ĂĐƚŝǀŝƚǇĂƌĞĚŝĨĨĞƌĞŶƚĨƌŽŵƚŚŽƐĞƌeported in Table 21 and Table 22. 
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Table 20: Care clusters and other mental health activity, 2011/12  ? 2014/15 
Community mental health 2011/12 2012/13 2013/14 2014/15 
 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Care Clusters 
        
Mental Health  W Care Clusters  W Admitted Patient Care 5,900,173 334 5,548,751 348 8,822,616 222 5,389,210 365 
Mental Health - Care Clusters - Non-Admitted Patient Care 208,657,970 11 244,072,900 9 239,045,781 9 245,102,673 9 
Mental Health  W Care Clusters  W Initial Assessment 418,356 251 816,112 264 746,982 281 755,151 293 
        
Total volume  ?DĞŶƚĂů,ĞĂůƚŚĂƌĞůƵƐƚĞƌƐ ? 214,976,499 20 250,437,763 17 248,615,379 17 251,247,034 17 
        
Other Mental Health 
       
Secure Units 1,537,140 523 1,526,840 532 1,543,448 516 1,565,824 522 
Day Care Facilities: Regular Attendances 28,782 294 34,969 294 41,555 305 30,482 318 
Outpatient Attendances* 1,343,458 156 615,632 217 721,849 182 1,019,875 184 
Community Contacts 3,309,410 135 2,970,529 161 2,642,912 188 3,285,139 173 
Specialist Teams 3,133,791 140 4,680,481 120 6,094,071 117 5,311,889 118 
        
Total volume Other Mental Health 9,352,581 204 9,828,451 203 11,043,835 195 11,213,209 197 
Total volume of Community MH activity 224,329,080 28 260,266,214 24 259,659,214 25 262,460,243 25 
Note: * Excludes Admitted Patient care, which is included in Hospital Mental Health 
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Table 21: Care clusters and other mental health activity, 2014/15  ? 2015/16 
Community mental health 2014/15 2015/16 
 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Care Clusters 
    
Mental Health  W Care Clusters  W Admitted Patient Care 5,389,210 365 5,269,507 388 
Mental Health - Care Clusters - Non-Admitted Patient Care 245,102,673 9 239,684,860 9 
Mental Health  W Care Clusters  W Initial Assessment 755,151 293 773,308 306 
     
dŽƚĂůǀŽůƵŵĞ ?DĞŶƚĂů,ĞĂůƚŚĂƌĞůƵƐƚĞƌƐ ? 251,247,034 17 245,727,675 18 
     
Other Mental Health * 
    
Children and Adolescent Mental Health Services 2,010,635 247 1,993,978 255 
Drug and Alcohol Services 2,019,664 100 1,519,640 105 
Mental Health Specialist Teams 1,887,758 162 2,111,275 165 
Secure Mental Health Services 1,565,824 522 1,570,096 524 
Specialist Mental Health Services 305,197 225 352,354 219 
 
    
Total volume Other Mental Health 7,789,078 243 7,547,343 254 
Total volume of Community MH activity 259,036,112 25 253,275,018 26 
Note: * Excludes Admitted Patient care, which is included in Hospital Mental Health 
 
Table 22: Care clusters and other mental health activity, 2015/16  ? 2016/17 
Community mental health 2015/16 2016/17 
 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Care Clusters 
    
Mental Health  W Care Clusters  W Admitted Patient Care 5,269,507 388 5,187,204 404 
Mental Health - Care Clusters - Non-Admitted Patient Care 239,684,860 9 236,183,269 9 
Mental Health  W Care Clusters  W Initial Assessment 773,308 306 822,296 301 
Adult IAPT Mental Health Care Clusters 1,038,873 275 886,645 310 
Adult IAPT Mental Health Care Clusters Initial Assessments 602,437 115 726,002 127 
     
dŽƚĂůǀŽůƵŵĞ ?DĞŶƚĂů,ĞĂůƚŚĂƌĞůƵƐƚĞƌƐ ? 247,368,985 19 243,805,416 18 
     
Other Mental Health * 
    
Children and Adolescent Mental Health Services 1,993,978 255 2,418,240 234 
Drug and Alcohol Services 1,519,640 105 1,270,174 110 
Mental Health Specialist Teams 2,111,275 165 2,101,077 171 
Secure Mental Health Services - - - - 
Specialist Mental Health Services 352,354 219 424,732 223 
 
    
Total volume Other Mental Health 5,977,247 183 6,214,223 187 
Total volume of Community MH activity 253,346,232  23 250,019,639 24 
Note: * Excludes Admitted Patient care, which is included in Hospital Mental Health 
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In terms of raw activity, Community Mental Health decreased by 1.3% from 2015/16 to 2016/17; the 
cost -weighted output growth measure, however, increased by 1.35% over the same time period, 
which is possibly due to the increase in the average costs associated with some of the Community 
Mental Health activity, as shown in Table 22. 
 
2.3.8 Rehabilitation and renal dialysis 
The volume of rehabilitation and renal dialysis activity over time is reported in Table 23. The 
Laspeyres output growth for Rehabilitation and Renal Dialysis services were, respectively, -3.1% 
and 2.1% between 2015/16 and 2016/17. 
 
Table 23: Rehabilitation and renal dialysis 
Year Rehabilitation Renal dialysis  
Volume 
of activity 
Average 
cost Volume 
of activity 
Average 
cost 
(£) (£) 
2004/05 4,095,087 178 8,232,432 52 
2005/06 4,509,489 185 6,819,136 64 
2006/07 3,028,598 241 4,200,298 104 
2007/08 2,732,048 259 3,980,793 114 
2008/09 3,277,757 265 4,091,245 120 
2009/10 3,277,430 279 4,050,658 129 
2010/11 3,314,085 285 4,088,817 129 
2011/12 2,897,721 278 4,166,150 129 
2012/13 2,715,650 301 4,135,914 128 
2013/14 3,002,512 298 4,069,460 131 
2014/15 3,008,889 317 4,070,447 131 
2015/16 2,985,717 332 4,157,008 134 
2016/17 2,893,451 332 4,240,850 134 
 
.  
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2.3.9 Specialist services 
This NHS setting includes the following specialist services: Adult critical care, Specialist palliative 
care, Cystic Fibrosis and Cancer multi-disciplinary team meetings; their volumes and costs are 
reported in Table 24. 
Table 24: Specialist services 
Year Adult critical care Specialist palliative care Cystic fibrosis 
Cancer multi-
disciplinary team 
meetings  
Volume 
of activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume 
of 
activity 
Average 
cost (£) 
Volume 
of activity 
Average 
cost (£) 
2004/05 2,184,333 828 - - 16,317 1,919 - - 
2005/06 2,197,135 895 - - 13,704 2,316 - - 
2006/07 2,468,777 840 93,880 269 13,944 2,290 - - 
2007/08 2,165,060 931 208,410 219 15,383 2,349 - - 
2008/09 2,354,447 967 262,305 216 20,756 2,116 - - 
2009/10 2,439,661 1,003 359,121 192 20,323 2,468 - - 
2010/11 2,470,065 1,011 512,972 162 19,942 2,631 - - 
2011/12 2,570,571 998 550,417 166 9,852 8,476 837,418 114 
2012/13 2,669,343 984 600,848 169 9,735 8,709 1,079,297 106 
2013/14 2,708,897 992 701,439 158 9,990 10,213 1,279,567 101 
2014/15 2,746,664 1,044 775,488 157 10,767 9,810 1,434,580 111 
2015/16 2,777,403 1,081 855,702 146 11,845 9,100 1,517,387 111 
2016/17 2,792,536 1,082 914,564 152 11,489 9,198 1,708,174 111 
 
The total volume of Adult Critical Care services increased by 0.5%, that of Specialist Palliative care by 
6.9%, Cystic Fibrosis raw activity decreased by 3.01% and the total volume of Cancer Multi-
Disciplinary Team Meetings activity increased by 12.6% between 2015/16 and 2016/17. 
 
Taken together, the Laspeyres output growth measure for Specialist Services increased by 1% 
between 2015/16 and 2016/17. 
 
2.3.10 Other Reference Cost activities 
Other types of activity reported in the Reference Costs are summarised in Table 25. The 
categorisation of these activities has changed somewhat over the series covered in this report, with 
some type of activities being either discontinued or subsumed under other broader categories.  
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Table 25: Regular admissions, ward attenders and day care 
Year 
Regular day and 
night admissions 
Audiological services Day care facilities 
Hospital at 
home/Early 
discharge schemes  
Volume 
of 
activity 
Average 
cost (£) 
Volume 
of activity 
Average 
cost (£) 
Volume 
of 
activity 
Average 
cost (£) 
Volume 
of 
activity 
Average 
cost (£) 
2004/05 122,447 248 1,902,390 41 735,070 124 434,698 73 
2005/06 177,131 245 1,692,721 40 649,963 131 593,586 60 
2006/07 179,927 271 2,905,175 50 439,932 135 470,737 74 
2007/08 164,651 324 3,447,049 51 384,048 137 405,271 73 
2008/09 198,573 341 3,716,333 51 345,371 159 522,047 68 
2009/10 152,079 393 3,807,539 52 319,706 156 495,961 81 
2010/11 176,169 431 3,927,780 51 321,386 148 364,352 91 
2011/12 176,877 428 4,033,290 50 275,819 140 323,213 113 
2012/13 210,984 371 4,030,693 52 237,040 157 285,754 108 
2013/14 204,831 400 3,483,549 55 239,032 146 - - 
2014/15 223,302 355 2,918,029 60 266,333 131 - - 
2015/16 224,523 389 3,523,847 57 241,756 131 - - 
2016/17 242,322 325 3,452,571 57 191,547 125 - - 
 
The total volume of RDNA activity increased by 7.9%, whilst the total volume of Audiological services 
and of Day Care Facilities decreased respectively by -2% and -20.8% between 2015/16 and 2016/17. 
Hospital at Home services are now captured under Community Intermediate Care activities in the 
community care setting. 
 
The Laspeyres cost-ǁĞŝŐŚƚĞĚŽƵƚƉƵƚŐƌŽǁƚŚŵĞĂƐƵƌĞĨŽƌ ?KƚŚĞƌE,^ĂĐƚŝǀŝƚǇ ? decreased by 2.6% 
between 2015/16 and 2016/17. 
 
2.3.11 Total Reference Cost growth 
NHS activity as captured by the Reference Cost returns grew by 2.73% if we include Outpatient 
activity and by 2.74% if Outpatient activity is excluded from the series. 
  
30  CHE Research Paper 163 
 Dentistry and ophthalmology 
Information about dentistry is derived from the NHS Digital website10 with dental activity 
differentiated into dental bands, as shown in Table 26. 
 
Output for all dental services, except for those in Band 1, has continued to decrease in 2016/17. 
Overall, the Laspeyres growth rate for dental activity decreased by 0.68% between 2015/16 and 
2016/17. 
 
Data about the volume of activity for ophthalmology are published by NHS Digital on a bi-annual 
basis.11  
Table 27 presents the volume of activity and cost for ophthalmic services over time. For the last two 
financial years, cost data for Ophthalmological services are those provided by the Association of 
Optometrists. The new cost data are reported in the last column of Table 27. 
                                                             
10 https://digital.nhs.uk/data-and-information/publications/statistical/nhs-dental-statistics/nhs-dental-statistics-for-
england-2016-17 ( last accessed12/03/2019) 
11 https://digital.nhs.uk/data-and-information/publications/statistical/general-ophthalmic-services-activity-
statistics/general-ophthalmic-services-activity-statistics-england-year-ending-31-march-2017 (last accessed 12/03/2019) 
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Table 26: Dental services 
Year Dentistry   
  Band 1 Band 2 Band 3 Urgent Other Total 
  Volume 
activity 
Av cost 
(£) 
Volume 
activity 
Av cost 
(£) 
Volume of 
activity 
Av cost 
(£) 
Volume 
activity 
Av cost 
(£) 
Volume  
activity 
Av cost 
(£) 
  
2004/05* 
          
2,241,095,331 
2005/06* 
          
2,433,471,413 
2006/07 19,012,890 16 10,687,669 42 1,529,129 189 2,881,205 16 939,871 16 1,096,089,020 
2007/08 19,275,334 17 10,991,870 46 1,684,537 198 3,133,209 17 901,975 17 1,219,391,145 
2008/09 19,803,371 17 11,489,585 46 1,859,524 198 3,343,459 17 930,279 17 1,289,383,127 
2009/10 20,346,012 17 11,699,635 46 2,086,179 198 3,509,055 17 948,634 17 1,355,827,865 
2010/11 20,718,874 17 11,804,774 46 2,187,483 198 3,615,027 17 918,371 17 1,388,081,816 
2011/12 20,886,648 17 11,862,329 46 2,217,060 198 3,685,411 17 919,217 17 1,400,506,136 
2012/13 21,016,444 18 11,750,849 48 2,239,287 209 3,712,031 18 603,054 18 1,475,353,493 
2013/14 21,685,314 18 11,801,493 49 2,232,243 214 3,852,470 18 190,216 18 1,519,077,159 
2014/15 22,028,232 19 11,446,920 51 2,177,960 219 3,780,401 19 178,531 19 1,535,805,234 
2015/16 22,437,889 18.8 11,251,942 51 2,129,467 223 3,693,752 19 169,831 19 1,545,498,706 
2016/17 22,939,419 20 11,080,848 54 2,082,785 234 3,664,913 20 156,905 20 1,611,200,931 
Note: Total value of dentistry activity for the years 2004/05 and 2005/06 is not directly comparable to following years, as it comes from a different data source (DH). 
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Table 27: Volume and average cost in ophthalmology 
Year Ophthalmology 
 
Volume of 
activity 
Average 
cost (£) 
Average 
cost (£) - 
New 
source 
2004/05 10,148,978 33  
2005/06 10,354,682 35  
2006/07 10,484,922 36 19 
2007/08 11,047,890 28 19 
2008/09 11,278,474 28 20 
2009/10 11,811,651 28 20 
2010/11 11,938,529 28 21 
2011/12 12,305,727 28 21 
2012/13 12,339,253 28 21 
2013/14 12,787,430 28 21 
2014/15 12,764,485 28 21 
2015/16 12,979,762 28 21 
2016/17 12,995,512 28 21 
 
Ophthalmic activity increased only slightly, 0.1%, between financial years 2015/16 and 2016/17. 
As the average costs have not changed since 2010/11, cost-weighted output growth measure is 
simply the growth in the volume of activity. 
 
Combining activity for dental services and ophthalmology, the cost-weighted output growth is 
 -0.53% between 2015/16 and 2016/17.  
 
 Primary care activity 
Table 28 summarises the data sources for primary care consultations used since 2004/05. 
 
Table 28: CHE primary care evidence sources 
Year Activity Source Cost source 
2004/05-2008/09 QResearch 
PSSRU cost estimates 2008/09-2009/10 General Lifestyle Survey 
2009/10 -current GP Patient Survey 
 
QResearch (QR) was the initial source of data used to measure primary care output (Fenty et al., 
2006) and it divided primary care consultations into a subset of activity, based on location (surgery, 
home, phone) and type of contact (GP, practice nurse, other). 
 
In  ? ? ? ? ? ? ? ?, ?ƐƐŽƵƌĐĞ of primary care data switched to survey based measures. This was initially 
the General Lifestyle Survey (GLS), but from 2010/2011 onwards, the GP Patient Survey (GPPS). In 
the GP Patient Survey, patients are asked when they last had any contact with their GP or nurse 
within the last three months. The responses are then extrapolated to reflect a number of contacts 
over the course of a year. Further, the GP Patient Survey does not ask the interviewees to state the 
type of contact they had or the location; thus, we assume that the distribution of contacts as 
observed in the 2008/09 QResearch data is unchanged for all subsequent years. This is obviously a 
shortcoming of our data, as the distribution of patients seen by different members of staff or in 
Productivity of the English NHS: 2016/17 update  33 
different locations may well have changed in recent years, due to the high pressure faced by general 
practitioners and the introduction of new healthcare professionals roles in primary care as set out in 
the General Practice (GP) Forward View (2016). 
 
The methods used to estimate consultation rates and the population growth adjustment are based 
on Bojke et al. (2017). Figure 8 reports the population shares for 2008/09 and 2016/17, as well as 
the average number of consultations, which is also computed on the population proportions of 
2008/09. As for the previous years, we observe a shift in the age of population with respect to the 
base year (2008/09), this means that compared to 2008/09 the share of the older population is 
growing faster than that of the youngest people. As a consequence, we would expect an increase in 
the number of consultations, given that older people tend to consult the GP more often than 
younger ones. However, starting from 2013/14 the percentage of people interviewed who declared 
to have seen a GP in the last three months is slowly decreasing. This is, however, not true for nurse 
contacts, as the percentage of interviewed people who have seen a nurse in the previous three 
months has increased in the latest financial year (see Table 29).  
 
 
 
Figure 8: Population characteristics 
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Table 29: CHE GPPS based measure of volume of consultations 
Year 
Patients who 
report having 
seen a GP in 
previous 3 
months 
Patients who 
report having 
seen a nurse in 
previous 3 
months 
Number of 
consultations 
Population 
adjusted 
number of 
consultations 
Quality and 
population 
adjusted 
number of 
consultations 
QR      
2004/05    265,600 274,122 
2005/06    283,100 293,733 
2006/07    293,000 305,517 
2007/08    292,500 305,291 
2008/09    300,400 313,815 
GLS      
2009/10 53.55%  300,400 300,400 313,988 
GPPS      
2010/11 52.37%  293,517  303,355 
2011/12 54.00%  303,820  317,893 
Population Adjustment*     
2011/12 54.00%  303,764 319,661 334,468 
2012/13 54.83%  308,433 327,301 342,667 
2013/14 54.28%  305,328 328,199 343,942 
Age & Gender Adjustment     
2013/14** 54.28% 35.91% 301,253 314,366 329,415 
2014/15** 53.28% 35.86% 298,024 313,865 328,965 
2015/16** 51.47% 34.81% 288,092 306,093 321,736 
2016/17 50.32% 35.87% 287,569 313,792 328,841 
Notes: * The population-adjustments are based on estimates for England only, and since 2013/14 these have also been 
adjusted for age and gender.  
** Up to 2013/14, the number of consultations was based on those reporting they had seen a GP within the previous 3 
months. From 2013/14 onwards ?ƚŚĞŶƵŵďĞƌĂůƐŽŝŶĐůƵĚĞƐƚŚŽƐĞǁŚŽ ?ĚƐĞĞŶĂƉƌŝŵĂƌǇĐĂƌĞŶƵƌƐĞ ?ƐĂďĂƐĞůŝŶĞ ?ƚŚŝƐ
calculation also takes the number of consultations reported by QResearch for the 2008/09 financial rather than calendar 
year (303,900,000) (http://content.digital.nhs.uk/pubs/gpcons95-09).  
 
The numbers of primary care consultations reported in Table 29 do not constitute a consistent 
historic series and should not be interpreted or used as such. For the historic series, please see 
Appendix D in Castelli et al. (2018). 
 
The total number of consultations is broken down into types of consultations by using the relative 
shares as measured by QResearch in 2008/09. Cost information for different types of consultation is 
derived from the PSSRU Unit Costs of Health and Social Care publication, as shown in Table 30. 
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Table 30: PSSRU unit costs for consultation types (£) 
Year GP Home visit GP Telephone GP Surgery 
GP 
Other 
Practice Nurse Other Consultations 
2004/05 69 30 24 24 10 15 
2005/06 69 27 24 24 10 15 
2006/07 55 21 34 34 9 14 
2007/08 58 22 36 36 11 15 
2008/09 117 21 35 35 11 14 
2009/10 120 22 36 36 12 17 
2010/11 121 22 36 36 13 25 
2011/12 110 26 43 43 14 25 
2012/13 114 27 45 45 13 25 
2013/14 114 28 46 46 14 25 
2014/15 114 27 44 44 14 25 
2015/16 114 15a 36b 36 11 N/A 
2016/17 114 15 37 37 11 N/A 
Notes: a Estimates extracted from a telephone triage GP-lead cost estimates; b Duration of GP consultation contact has 
been reduced from 11.7 to 9.22 minutes. 
 
The quality of primary care activity is measured limitedly to Coronary heart disease, Stroke and 
Hypertension and are accounted for using the Quality & Outcomes Framework (QOF) achievement 
indicators.12 (Derbyshire et al., 2007) 
 
The data on prevalence are taken from Annex 1 of the QOF report and data on success rates are 
obtained from the Clinical results tables, also in the same report.13 As shown in Table 31 the QOF 
achievement for 2016/17 increased with respect to the previous financial year. As a consequence, 
the quality-adjusted primary care output growth between 2015/16 and 2016/17 is expected to be 
higher than that recorded in the previous two financial years.   
   
  
                                                             
12 These are QOF CHD002 for Coronary Heart Disease, STIA003 for Stroke and HYP006 for Hypertension. 
13 https://digital.nhs.uk/data-and-information/publications/statistical/quality-and-outcomes-framework-achievement-
prevalence-and-exceptions-data/quality-and-outcomes-framework-qof-2016-17 (last accessed 30/01/2019). 
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Table 31: Quality adjustment for primary care (%) 
 
The Laspeyres growth rates for primary care activity are reported in Table 32. 
 
Table 32: Laspeyres growth rates for primary care 
Years Unadjusted 
Growth rate 
Population 
adjusted growth 
rate 
Population and 
quality 
adjusted 
growth rate 
2004/05-2005/06 
 
6.59% 7.15% 
2005/06-2006/07 
 
3.50% 4.01% 
2006/07-2007/08 
 
-0.17% -0.07% 
2007/08-2008/09 
 
2.70% 2.79% 
2008/09-2009/10 
 
0.00% 0.06% 
2009/10 - 2010/11 -2.61% -1.11% -0.99% 
2010/11 - 2011/12 3.83% 4.66% 4.70% 
2011/12 - 2012/13 1.54% 2.39% 2.45% 
2012/13 - 2013/14 -1.01% 0.27% 0.37% 
2013/14 - 2014/15 -1.07% -0.16% -0.14% 
2014/15 - 2015/16 -3.33% -2.48% -2.51% 
2015/16 - 2016/17 -0.18% 0.86% 0.89% 
 
Looking at the last financial year, the growth in primary care consultations, as emerged from the GP 
survey data, is still negative (-0.18%), but it is showing an improvement compared to previous years. 
Accounting for population growth has a positive impact bringing the growth in primary care 
consultations up to 0.86% from a two consecutive yearƐ ? negative growth. Finally, adjusting for 
quality of care adds a further 0.03 percentage points to the growth. This is entirely due to better 
results in the QOF achievements for both CHD and Hypertension. 
 
Year Prevalence QOF achievement 
 
CHD Stroke Hypertension CHD Stroke Hypertension 
2004/05 3.57 1.63 10.41 78.6 73.13 64.33 
2005/06 3.57 1.66 11.48 84.44 81.22 71.05 
2006/07 3.54 1.61 12.49 88.86 86.92 77.62 
2007/08 3.50 1.63 12.79 89.41 87.51 78.35 
2008/09 3.47 1.66 13.13 89.68 87.88 78.56 
2009/10 3.44 1.68 13.35 89.77 88.12 78.72 
2010/11 3.4 1.71 13.52 90.16 88.57 79.3 
2011/12 3.38 1.74 13.63 90.14 88.61 79.65 
2012/13 3.40 1.7 13.68 90.57 89.26 80.79 
2013/14 3.29 1.72 13.73 91.27 89.84 83.09 
2014/15 3.25 1.73 13.79 91.98 88.17 83.61 
2015/16 3.20 1.74 13.81 91.89 87.63 82.9 
2016/17 3.15 1.75 13.83 92.43 88.06 83.36 
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 Community prescribing 
Data about community prescribing are derived from the Prescription Cost Analysis (PCA) system, 
supplied by the Prescription Pricing Authority via the NHS Digital Prescription Drugs Team. The data 
are based on a full analysis of all prescriptions dispensed in the community, summarised into 
different categories defined according to chemical composition. The data include information about 
the Drug code (PropGenLinkCode), Net Ingredient Cost (NIC), Quantity of Drug Dispensed, and 
Number of Prescription Items. The data are complete and prices are available for all items across the 
years.  
 
Table 33 reports summary statistics about community prescribing. Drugs are categorised according 
to their chemical composition, with the number of categories changing over time. From the peak 
number of categories reported in 2004/05 (8,779 categories), the number of categories decreased, 
reaching an all-time low in 2013/14 (7,809 categories) before picking up again. However, some of 
these variations are usually due to zero counts in some years, rather than definitional changes which 
are in fact stable over time. 
 
In 2016/17, the data report information on 8,147 distinct community prescribed drug items 
corresponding to an increase of 21 million prescriptions compared to the previous year. On the 
contrary, the total cost in 2016/17 decreased and it is approximately £9.2 billion, almost £100 
million less than in 2015/16. These estimations are in line with those published in the 2017 Official 
Statistics Reports on Prescription Cost Analysis (Prescribing & Medicines Team, 2018). 780 new drug 
items appeared in 2016/17 for a total spending of £61 million, and 654 drug items were not 
prescribed in the same year corresponding to a lagged total cost of £29 million. There are no data 
items which appear obviously incorrect and we therefore take the data at face value. 
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Table 33: Community prescribing, summary data 
Year 
Unique 
drug 
codes 
observed 
Total Prescribing Total Spend 
Activity 
weighted 
average 
prescription 
unit cost (£)  
2004/05 8,779 691,948,868 £8,094,174,944 11.7 
2005/06 8,535 733,010,929 £8,013,483,226 10.93 
2006/07 8,218 762,631,738 £8,250,323,893 10.82 
2007/08 8,769 803,297,137 £8,303,500,918 10.34 
2008/09 8,276 852,482,281 £8,376,264,432 9.83 
2009/10 8,072 897,727,347 £8,621,421,130 9.6 
2010/11 7,860 936,743,859 £8,880,735,344 9.48 
2011/12 7,856 973,381,568 £8,777,964,802 9.02 
2012/13 7,699 1,001,825,994 £8,397,492,181 8.38 
2013/14 7,353 1,031,703,347 £8,540,423,964 8.28 
2013/14* 7,809 1,039,535,998 £8,703,169,718 8.37 
2014/15 7,926 1,071,065,672 £8,942,734,216 8.35 
2015/16 8,021 1,087,838,465 £9,288,424,660 8.54 
2016/17 8,147 1,108,965,909 £9,193,912,893 8.29 
Note: * In February 2017, NHS Digital released a new set of prescribing data to include previously omitted drug codes. The 
2012/13-2013/14 growth figures for prescribing are based on the earlier data; whilst the 2013/14-2014/15 growth figures 
are based on the new data. 
 
From the data we observe changes in average cost of prescription and in unit (i.e. item) cost over 
recent years (Table 33). Output and price indices for community prescribing are reported in Table 
34. Prices have fallen year-on-year over the whole period, the drop is much higher in 2016/17 
compared to 2015/16, and it is equal to about -7%. 
 
Table 34: Community prescribing: price and volume growth 
Years 
Paasche 
Price 
Ratio 
Laspeyres 
Volume 
Ratio 
2004/05 - 2005/06 0.9014 1.0984 
2005/06 - 2006/07 0.9659 1.0659 
2006/07 - 2007/08 0.9376 1.0735 
2007/08 - 2008/09 0.9485 1.0636 
2008/09 - 2009/10 0.9626 1.0693 
2009/10 - 2010/11 0.9833 1.0476 
2010/11 - 2011/12 0.9564 1.0335 
2011/12 - 2012/13 0.9284 1.0356 
2012/13 - 2013/14 0.9855 1.032 
2013/14 - 2014/15* 0.9869 1.0411 
2014/15 - 2015/16 0.9993 1.0394 
2015/16 - 2016/17 0.9300 1.0644 
Note: * In February 2017, NHS Digital released a new set of prescribing data to include previously omitted drug codes. The 
2012/13-2013/14 growth figures for prescribing are based on the earlier data; whilst the 2013/14-2014/15 growth figures 
are based on the new data. 
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On the contrary, the Laspeyres output growth measure for prescriptions has continued to increase 
and the year-on-year growth is equal to 6.4% between 2015/16 and 2016/17. 
 
Taking the base year as 2004/05, trends in the volume and prices of pharmaceuticals are shown in 
Figure 9. 
 
 
Figure 9: Price and volume changes for community prescribed pharmaceuticals 
Note: * In February 2017, NHS Digital released a new set of prescribing data to include previously omitted drug codes. The 
2012/13-2013/14 growth figures for prescribing are based on the earlier data; whilst the 2013/14-2014/15 growth figures 
are based on the new data.  
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 Output growth 
Output growth is measured by combining activities of different types into a single index, using costs 
to reflect their values. As shown in Table 35, the cost-weighted output growth index increased by 
3.35% between 2015/16 and 2016/17. 
 
Re-scaling each type of cost-weighted output, where appropriate and feasible, according to changes 
in survival, health improvements, waiting times, and blood pressure monitoring generates the 
quality-adjusted index. This increased by 3.51% between 2015/16 and 2016/17. This is about 0.16% 
higher than the cost-weighted index, with improvements registered in some of the quality measures 
(survival rates, life expectancy, QOF achievements in primary care for CHD and Hypertension) and 
deteriorations in others (waiting times and QOF achievement in primary care for Stroke). 
 
Table 35: Output growth 
Years All NHS 
 Cost-weighted 
growth 
Quality adjusted 
CW growth 
2004/05  ? 2005/06 6.53% 7.11% 
2005/06  ? 2006/07 5.88% 6.50% 
2006/07  ? 2007/08 3.41% 3.66% 
2007/08  ? 2008/09 5.34% 5.73% 
2008/09  ? 2009/10 3.44% 4.11% 
2009/10  ? 2010/11 3.61% 4.57% 
2010/11  ? 2011/12 2.38% 3.15% 
2011/12  ? 2012/13 2.58% 2.34% 
2012/13  ? 2013/14 2.37% 2.64% 
2013/14  ? 2014/15 2.53% 2.49% 
2014/15  ? 2015/16 2.16% 2.58%* 
2015/16  ?2016/17 3.35% 3.51% 
* The quality adjusted CW growth rate for 2014/15  W 2015/16 differs from the one reported in Castelli et al. (2018) as it has 
been updated to reflect a change in the methods of assigning PROMs to HES activity with UZ01 code. Please refer to 
Section 2.2.2 for full details. 
 
2.7.1 Contribution by settings 
Not all settings contribute equally to the output index. Figure 10 shows the share of overall spend 
for each of the settings as well as contribution to growth, calculated as a share of overall spend 
multiplied by the output growth of the setting. More detailed information on contribution of each 
setting can be also found in Table 36. 
 
By far the largest contributor to the output index is HES inpatient activity, with a share of over 30% 
of both total spend and overall output growth. Other sizeable contributors are Outpatient activity, 
Primary care, Community prescribing and Community Mental Health. All other settings contribute 
less than 6% to total spend or output. 
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Figure 10: Contribution by setting, 2016/17 
 
Table 36: Contribution of setting to growth, 2016/17 
Setting Growth Setting 
specific 
growth 
index 
Value of Activity 
(15/16 prices) 
Share of 
overall 
spend 
Contribution 
to growth 
      
All HES* 3.6% 103.6% 27,638,191,417 31.83% 32.96% 
Outpatient* 5.3% 105.3% 12,677,072,886 14.60% 15.38% 
Community Prescribing 6.4% 106.4% 9,288,424,660 10.70% 11.39% 
Primary care* 0.9% 100.9% 8,860,359,095 10.20% 10.29% 
Community Mental Health 1.3% 101.3% 5,841,604,305 6.73% 6.81% 
Community care 2.3% 102.3% 5,171,028,803 5.96% 6.09% 
A&E 2.2% 102.2% 4,454,964,482 5.13% 5.24% 
Chemo-/Radiotheraphy/High Cost Drugs 8.4% 108.4% 3,697,167,367 4.26% 4.61% 
Specialist Services 1.0% 101.0% 3,402,452,724 3.92% 3.96% 
Ophthalmology & Dentistry -0.5% 99.5% 1,902,442,161 2.19% 2.18% 
Radiology 6.8% 106.8% 1,048,541,345 1.21% 1.29% 
Diagnostic Tests 4.2% 104.2% 984,825,204 1.13% 1.18% 
Rehabilitation -3.1% 96.9% 990,073,776 1.14% 1.10% 
Renal Dialysis 2.1% 102.1% 556,027,298 0.64% 0.65% 
Other -2.6% 97.4% 319,329,769 0.37% 0.36% 
      
Total/ NHS Output growth rate 
  
86,832,505,292 
 
3.51% 
*All HES, Primary Care and Outpatient activity are quality adjusted. ** The contribution of each setting to growth in 2016/17 
is expressed as a percentage of the total output in 2015/16. Where numbers in this column are lower than numbers in the 
preceding column, this represents negative growth in output for that sector.  
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3 Inputs 
Inputs into the health care system consist of: 
 
x Labour, such as doctors, nurses, technicians and managers; 
x Materials and supplies, such as drugs and disposable items; 
x Capital, such as buildings and equipment with an asset life of more than a year. 
 
We construct a comprehensive index of input growth, using the workforce data and organisational 
accounts submitted by NHS organisations together with other forms of expenditure data. These data 
are used to quantify the amount of all inputs used in the production of health care provided to NHS 
patients. 
 
For capital and materials we use expenditure data. Labour data come from two sources: expenditure 
data as well as staff numbers from the Electronic Staff Record (ESR). We explore the growth 
consequences of using these alternative data sources for measuring labour input. We report 
estimates for two different formulations of the input index. Our mixed index uses information about 
labour inputs recorded in the ESR and expenditure for everything else; our indirect method uses 
expenditure data for all types of input. 
 
 Direct labour  
Since 2007/08 we have used ESR data to calculate growth in labour inputs.14 These data are obtained 
from the NHS iView database15 which draws data directly from the ESR, and combined Payroll and 
Human Resources system for the NHS. The data contain the number of full time equivalent (FTEs) 
staff and earnings for over 580 different occupational groups. All staff employed by NHS 
organisations are included.16 Where 5 or less staff members are employed in a particular staff group, 
the organisation randomly reports either 5 or 0. For this reason, the reported total number of staff 
constructed using the ESR source data differs from the aggregated figures published by NHS Digital.17 
 
The ESR data collection method was updated in March 2016, resulting in several developments to 
improve the quality of data available. A complete list of developments was published by NHS Digital 
in 2016 and a notice on the implemented changes is available on NHS Digital website.18 The 
implications of this general change in methodology are discussed in Castelli et al. (2018).  
 
Data on staff earnings come from a separate dataset, also provided by NHS Digital, which includes all 
earnings data submitted by NHS organisations for staff paid directly by the NHS. This dataset 
contains average earnings by occupational group.19 In our calculation we sum basic and non-basic 
pay to get total earnings for each staff group. As non-basic pay is not reported by FTEs, but only by 
headcount, we multiply non-basic pay first by an FTE/headcount ratio to get the equivalent FTE 
number (as advised by NHS Digital).  
 
From November 2016, information about FTE staff and earnings by category is reported separately 
ĨŽƌ ‘ĐŽƌĞ ?ĂŶĚ ‘ǁŝĚĞƌ ?ƐĞƌǀŝĐĞƐ ?ŽƌĞƐĞƌǀŝĐĞƐĂƌĞŵĂĚƵƉŽĨŚŽƐƉŝƚĂůdƌƵƐƚƐĂŶĚĐŽŵŵŝƐƐŝŽŶŝŶŐ
                                                             
14 Up to 2006/07, we used data from the Workforce Census to count the number of staff working in the NHS. 
15 https://digital.nhs.uk/services/iview-and-iviewplus (last accessed 19/03/2019) 
16 tĞĚƌŽƉ^ZƌĞƚƵƌŶƐŵĂĚĞďǇƉƌŝǀĂƚĞƉƌŽǀŝĚĞƌƐ ?E,^ƌŵ ?Ɛ-length bodies, Special Health Authorities and other NHS bodies 
that report to the ESR but do not fall in the included categories (e.g. Sussex Health Informatics Service (YDD81) ) 
17 https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics (last accessed 
19/03/2019) 
18 https://digital.nhs.uk/data-and-information/areas-of-interest/workforce (last accessed 19/03/2019) 
19 In the past we had information on total earnings per month, without separation in basic/non-basic. 
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bodies. Wider services are made up of central support services such as NHS England. In order to be 
comparable with 2015/16 data, we reconstruct the total of FTE staff and wage in each category 
across core and wider services. For FTE staff, a sum is taken in each category. For wages, a weighted 
average is calculated for each staff category, where proportion of FTE staff in the relevant service act 
as weights. If a wage is only available for a single service type, we assume this wage also reflects the 
average for equivalent staff in the other service type. 
 
Gradually more and more Clinical Commissioning Groups (CCGs) have been reporting ESR data, 
although for the financial year 2016/17 6 CCGs out of 210 are still not doing so (Table 37).  
 
Table 37: Number of reporting entities by organisation type 
Organisation 
type 
2010/11 2011/12 2012/13 2013/14 2014/15 2014/15a 2015/16 2016/17 
CCGs n/a n/a 9 152 202 202 201 204 
CSUs 0 0 0 24 25 22 11 8 
NHS England 0 0 1 1 1 1 1 1 
Non-
geographical 
staff 
0 1 1 1 1 1 1 1 
PCTs 147 142 132 40 26 10 0 0 
SHA 10 10 10 2 0 4 0 0 
NHS Trusts 248 260 260 251 249 249 240b 239 
Note: CCGs: Clinical Commissioning Groups; CSUs: Commissioning Support Units; Non-Geographic Central Staff, code AHO; 
PCTs: Primary Care Trusts; SHA: Strategic Health Authorities; n/a not applicable. 
a This column corresponds to NHS staff numbers for the financial year 2014/15 updated to the new methodology 
implemented by NHS Digital in March 2016. 
b The total number of NHS Trusts for 2015/16 is 240, and not 249 as previously reported in Castelli et al. (2018). 
 
Table 38 shows expenditure by organisational type as determined by the summed product of staff 
group FTEs and average earnings. The major trends of increasing expenditure from Trusts and CCGs 
recorded since 2014/15, continues in 2016/17. The proportional increase in expenditure on staff in 
CCGs has been large over the past two years. This is as expected as more CCGs have reported to the 
ESR dataset over time. There is also a sharp increase in non-geographic staff. However, the impact of 
this figure on overall staff expenditure is modest and remains within the range of expenditure on the 
same staff group in previous years. 
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Table 38: Expenditure on labour in current prices (£m) 
Organisation 
type 
2010/11 
(£) 
2011/12 
(£) 
2012/13 
(£) 
2013/14 
(£) 
2014/15 
(£) 
2014/15 
(£)a 
2015/16 
(£) 
2016/17 
(£) 
CCGs 0 0 7 434 535 530 61920 722 
CSUs 0 0 0 318 306 333 261 211 
NHS England 0 0 1 221 205 202 171 173 
Non-
geographical 
staff 
0 157 143 76 71 16 8 57 
PCTs 5,822 3,742 1,329 89 1 0.15 0 0 
SHA 133 114 110 0.4 0 0.32 0 0 
NHS Trusts 28,809 31,761 33,753 34,510 35,820 35,131 36,319 37,492 
a This column corresponds to NHS staff numbers for the financial year 2014/15 updated to the new methodology 
implemented by NHS Digital in March 2016. 
 
The number of NHS staff, measured as Full Time Equivalents (FTEs), is reported in Table 39. Changes 
from 2015/16 to 2016/17 are similar to those observed in recent previous years. 
 
                                                             
20 A rounding error in reporting expenditure of CCGs in 2015/16 was found whilst updating the NHS productivity series; this 
figure should have been 619 and not 618 as reported in Castelli et al. (2018). 
Productivity of the English NHS: 2016/17 update  45 
Table 39: NHS staff numbers 
 2004/05 2005/06 2006/07 2007/08 2008/09 2009/10 2010/11 2011/12 2012/13 2013/14 2014/15 2014/15c 2015/16 2016/17 
GPs (a) 31,021 32,855 33,384 33,730 34,043 36,085 35,243 35,319 35,871 36,294 n/a n/a n/a n/a 
GP Practice staff 69,140 72,006 72,990 75,085 73,292 72,153 73,306 
      
 
GP Practice staff  ? 
new method 
      
82,802 84,609 85,546 87,114 n/a n/a n/a n/a 
Medical staff  (b) 78,462 82,568 85,975 84,811 90,460 93,393 95,531 99,331 100,878 100,797 104,189 102,764 104,009 105,565 
Ambulance staff 
   
21,149 23,084 24,489 25,056 24,908 24,566 24,757 25,381 25,028 26,008 27,451 
Administration and 
estates staff 
   
237,264 243,018 262,479 263,723 250,539 242,980 239,359 245,504 208,961 213,880 218,700 
Health care assistants 
and other support 
staff 
   
101,114 106,406 112,710 114,786 116,643 116,018 119,138 123,870 121,564 126,549 133,050 
Nursing, midwifery 
and health visiting 
staff and learners 
   
366,520 372,132 379,841 380,114 377,948 363,781 366,246 372,060 359,221 359,826 362,774 
Scientific, therapeutic 
and technical staff 
and healthcare 
scientists 
   
141,754 150,056 159,538 165,454 168,750 164,312 165,683 173,536 165,188 167,438 173,399 
Unknown and Non-
funded staff 
   
4,327 3,595 3,462 3,351 3,055 2,652 2,423 0 3,544 3,757 4,194 
Professionally 
qualified clinical staff 
412,013 425,044 425,983 
          
 
Support  to clinical 
staff 
271,347 278,994 273,202 
          
 
NHS infrastructure 
support staff 
178,530 186,510 178,230 
          
 
Total 
1,040,513 1,077,977 1,069,764 1,065,754 1,096,086 1,144,150 1,239,366 1,161,102 1,136,604 1,141,811 1,044,540 986,270 1,001,467 1,025,133 
Notes: a Data for GPs and GP practice staff are not available from ESR; Workforce Census data are used instead; there were also changes in counting of GP Practice staff, therefore data from 2010/11 onwards are not 
comparable to previous years. NHS Digital stopped reporting the GP figures in 2014/15. b FTE data up to 2006/07 are taken from the Workforce Census data. FTE data from 2007/08 onwards are taken from 
organisational returns of Electronic Staff Records. When there are 5 or less people employed in an occupational group, organisations report either 5 or 0; these totals therefore will differ from those derived from 
national level data. c This column corresponds to NHS staff numbers for the financial year 2014/15 updated to the new methodology implemented by NHS Digital in March 2016. 
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Table 40: Growth in direct labour 
Years Nominal expenditure growth Laspeyres volume growth 
 
All* Trusts All* Trusts 
2007/08  ? 2008/09 7.61% 7.21% 4.14% 3.77% 
2008/09  ? 2009/10 7.03% 6.55% 4.54% 4.15% 
2009/10  ? 2010/11 2.62% 3.70% 1.42% 2.95% 
2010/11  ? 2011/12 2.91% 10.25% 0.10% 7.26% 
2011/12  ? 2012/13 -1.21% 6.27% -1.97% 5.50% 
2012/13  ? 2013/14 0.87% 2.24% 0.38% 1.71% 
2013/14  ? 2014/15 3.67% 3.80% 2.80% 2.92% 
2014/15  ? 2015/16** 3.17% 3.38% 1.32% 1.47% 
2015/15  ? 2016/17 3.42% 3.19% 2.36% 2.19% 
Notes: *all organisations reporting to ESR except independent providers; arms-length bodies and special health authorities; 
** Nominal expenditure and Laspeyres growth figures for 2014/15  W 2015/16 are not directly comparable to previous years 
due to the implementation of the new methodology. 
 
Table 40 shows the growth in nominal expenditure and the Laspeyres input growth over time by all 
organisations submitting ESR data (i.e. Trusts plus PCTs, CCGs, CSUs, NHS England, SHAs and the 
non-geographical category) and hospital Trusts only.   
 
The growth rate for labour between 2015/16 and 2016/17 is positive, at 2.36% across the NHS 
overall and 2.19% within Trusts alone. These growth rates are larger than between 2014/15 and 
2015/16, though not as large as growth between 2013/14 and 2014/15. Unusually, growth in 
expenditure is slightly larger for the NHS overall than for Trusts alone.  
 
 Expenditure data 
The source of expenditure data has changed over time and by type of organisation, as summarised 
in Table 41. Data for Foundation Trusts are derived from the Consolidated NHS Financial Trust 
Accounts, the format of which has remained unchanged over the past decade. These accounts are 
less detailed than Trust Financial Returns (TFRs) reported by NHS Trusts, PCTs and SHAs up to and 
including 2011/12. The TFRs were discontinued in 2011/12 because of the reorganisation of the 
NHS. Aggregated information is now obtained from the DH Annual Report and Accounts.21 
 
For NHS Trusts, TFRs were replaced with Financial Monitoring and Accounts, although both reporting 
systems were used in 2011/12. The Financial Monitoring and Accounts are much less detailed than 
the TFRs, reporting information for very broad input categories. It is therefore no longer possible to 
report time series for specific input types. For instance, it is not possible to identify expenditure by 
NHS Trusts on agency staff from these accounts.22 Instead, we rely on data provided directly by the 
Department of Health to identify expenditure on agency staff. 
 
 
 
                                                             
21 https://www.gov.uk/government/publications/department-of-health-annual-report-and-accounts-2016-to-
2017;https://www.gov.uk/government/publications/department-of-health-annual-report-and-accounts-2015-to-2016 (last 
accessed 31/01/2019) 
22 http://www.parliament.uk/business/publications/written-questions-answers-statements/written-
question/Commons/2014-10-22/211600/ (last accessed 31/01/2019) 
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Table 41: Source of financial information 
Years 
Foundation 
Trusts 
NHS Trusts PCT/SHAs 
NHS 
England/CSUs/CCGs 
2004/05 - 2011/12  Trust Financial 
Returns 
PCT/SHA Financial 
Returns 
N/A 
 
2011/12 - 2012/13 
Consolidated 
NHS Financial 
Trusts Accounts 
 
Financial 
Monitoring and 
Accounts 
DH Annual 
Reports and 
Accounts 
DH Annual Reports 
and Accounts 
2012/13 - current N/A 
 
The use of more aggregated data, apart from the loss of detail, has two further implications for the 
construction of the input index: 
 
1. We have to apply deflators for the more aggregated input category. Thus, investigations into 
the contribution of volume and price to different inputs are more limited.23 
2. The annual accounts do not identify all items of capital. This makes it practically impossible 
to account for utilisation of different types of capital in each period, based on assumptions 
about their asset life and depreciation (Street and Ward, 2009), and thus to ascertain how 
much has been spent on capital in each period, and more importantly how much of the 
capital acquired has been utilised. 
 
The financial reporting items of expenditure designated as materials and capital in the most recent 
financial data are listed in Table 42 for NHS Foundation Trusts and NHS Trusts and CCGs/NHS 
England Group, separately. In 2016/17, the naming convention of items dealing with impairment 
changed.24 For example,  ‘Net Impairment Property, Plant and Equipment ? is a change from the 
previously used  ‘Impairment & reversals of property, plant and equipment ?. In order to ensure 
comparability of figures, the values reported for 2015/16 in the 2016/17 accounts were compared to 
the year 2015/16 in the 2015/16 accounts. For a single item ? ‘Net Impairment Property, Plant and 
Equipment ? there was a difference in the values reported. Therefore, to ensure comparability of 
figures, values for 2015/16 as reported in the 2016/17 accounts were used instead of the values 
reported in the 2015/16 accounts for this item of capital expenditure when calculating growth from 
2015/16 to 2016/17.25 
 
  
                                                             
23 We apply the Hospital and Community Health Services (HCHS) prices deflator for materials and capital. For labour and 
prescribing expenditure, we construct our own deflators using ESR and Prescription Cost Analysis data respectively. See in 
Table D1 in Appendix D the list of deflators. Up to 2015/16 we used a pay and prices deflator for primary care expenditure. 
For the 2015/16-2016/17 link, this deflator is not available. Therefore, we construct a pay and price deflator using the 
following formula 0.1 + 0.4*(ESR deflator) + 0.4*(HCHS). This formulation matches the one used previously by the DH to 
construct pay and price deflators from HSCI and a price deflator which draws in ESR data. 
24 Codes identifying different items of expenditure are unchanged. 
25 The impact is a reduction in the total value of capital expenditure in 2015/16 by £266,414 (2% of capital expenditure in 
2015/16 as reported in the previous publication).  
48  CHE Research Paper 163 
Table 42: Materials and capital items 
Organisation Materials Capital 
Foundation 
Trusts and 
NHS Trusts 
Source: 
Financial 
Monitoring & 
Accounts 
Consolidated 
NHS Financial 
Trusts 
Accounts 
Services from Other NHS Trusts 
Services from PCTs 
Services from Other NHS Bodies 
Services from Foundation Trusts 
Purchase of Healthcare from Non-NHS 
Bodies 
Supplies & Services - Clinical 
Supplies & Services - General 
Consultancy Services 
Transport 
Audit fees 
Other Auditors Remuneration 
Clinical Negligence 
Research & Development (excluding staff 
costs) 
Education & Training 
Establishment 
Other 
 
Premises 
Impairments & Reversals of Receivables 
Inventories write downs 
Depreciation 
Amortisation 
Net Impairment of Property, Plant & 
Equipment 
Net Impairment of Intangible Assets 
Net Impairment of Financial Assets 
Net Impairment for Non-Current Assets held 
for sale 
Net Impairments for Investment Properties 
 
   
CCGs/NHS 
England 
Group 
Source: 
DH Annual 
Report & 
Accounts 
Consultancy Services 
Transport 
Clinical Negligence Costs 
Establishment 
Education, Training & Conferences 
Supplies & Services - Clinical 
Supplies & Services - General 
Inventories consumed 
Research & Development Expenditure 
Other 
Premises 
Impairment of Receivables 
Rentals under operating leases 
Depreciation 
Amortisation 
Impairments & reversals 
Interest Charges 
 
3.2.1 Input use derived from expenditure data 
Table 43 presents expenditure data reported by PCTs, CCGs and NHS England Group. PCTs officially 
ceased to exist in 2013/14; their activity was partly taken over by CCGs, as well as by CSUs and NHS 
England, together forming the NHS England Group.  
 
Between 2015/16 and 2016/17 we observe an increase in expenditure on labour by 2.29%. 
Expenditure on materials fell by 12.53%, following a large increase in the previous year of 34.45%. 
Capital expenditure fell by 6.50%, similar in magnitude to the reduction observed in the previous 
year.  
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Table 43: Current expenditure by PCTs and NHS England Group, (£000) 
Organisation Year Labour Materials Capital 
PCTs 
2007/08 6,701,228 2,617,114 1,174,841 
2008/09 7,478,953 2,526,610 1,247,997 
2009/10 8,230,341 2,623,459 1,703,974 
2010/11 7,175,399 2,638,638 1,171,813 
2011/12 2,328,314 2,052,029 892,604 
2011/12* 2,358,373 860,860 1,721,795 
2012/13* 1,938,770 885,265 1,814,809 
NHS England 
Group 
2013/14* 1,529,067 1,420,027 696,400 
2014/15* 1,726,006 1,457,798 536,383 
2015/16* 1,741,655 1,960,006 502,897 
2016/17* 1,781,455 1,714,391 470,188 
* Data up to 2010/11 are taken from Financial Returns and from 2011/12 onwards from DH Annual Report and Accounts. 
Material and capital items are identified differently in each source 
 
Table 44 shows the expenditure for Labour, Materials and Capital for hospital Trusts.  
In the process of calculating growth from 2015/16 to 2016/17, an error was found in calculating 
expenditure in earlier years. Specifically, expenditure from two Trusts were not included in the totals 
calculated for each category. Therefore, Table 44 presents corrected figures for Labour, Materials 
and Capital in 2014/15 and 2015/16. For the previously reported figures, see Castelli et al. (2018). 
The inclusion of additional Trusts means an increase in Labour expenditure by £554 million (1.15% of 
Labour expenditure in 2015/16). For the same year, Materials increase by £397 million (1.23%) and 
Capital by £64 million (0.51%). Due to similar increases in expenditures in 2014/15, the impact of the 
additional Trusts on growth between 2014/15 and 2015/16 is modest. In Castelli et al. (2018), 
increases of 2.87%, 9.68% and -1.4% for Labour, Materials and Capital respectively are reported. 
After including the previously missing Trusts, growth in nominal expenditures between 2014/15 and 
2015/16 is found to be 3.34%, 10.32% and -1.2% respectively.  
Note that these comparisons do not include the change to impairments discussed in the previous 
section, as this only effects measurement of input growth between 2015/16 and 2016/17. A second 
2015/16 line, accounting for both the additional Trusts and changes to impairment, is also presented 
in Table 44; this is the comparator used in calculating growth from 2015/16 to 2016/17.  
In current terms, after accounting for the additional Trusts and changes to impairments noted 
above, Labour expenditure increased by 3.55% between 2015/16 and 2016/17. We observe larger 
proportional increases in spend on materials and capital of 4.74% and 9.10% respectively. 
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Table 44: Current expenditure by hospital Trusts (£000) 
Year Labour Materials Capital 
2007/08 30,884,556 10,140,836 6,452,630 
2008/09 33,435,219 11,322,441 6,340,019 
2009/10 35,983,781 12,115,273 6,529,977 
2010/11 38,222,951 12,961,217 6,839,898 
2011/12 42,647,889 14,941,588 7,278,435 
2011/12* 42,701,684 17,477,370 12,097,485 
2012/13* 43,797,935 19,681,855 12,377,259 
2013/14* 45,360,562 21,108,612 13,217,703 
2014/15*1 47,170,735 22,125,031 12,787,098 
2015/16*2 48,748,162 23,644,352 13,396,241 
2015/16*3 48,748,162 23,644,352 13,129,827 
2016/17* 50,479,070 24,765,135 14,324,055 
* For NHS Trusts, data up to 2011/12 are derived from Financial Returns; for 2011/12 and following years data are derived 
from Financial Monitoring and Accounts. Material and Capital items are identified differently in each source. 
1 Figures differ from Castelli et al. (2018) due to including expenditure from two Trusts, which were not part of previous 
equivalent figures. 
2 Figures differ from Castelli et al. (2018) due to including expenditure from two Trusts, which were not part of previous 
equivalent figures. In addition, impairment is allocated to capital instead of materials. 
3 Figure for 2015/16 used to calculate growth between 2015/16 and 2016/17. This uses information for 2015/16 from the 
2016/17 accounts where a naming convention has changed and the value of  ‘Net impairment property plant and 
equipment ? for 2015/16 differs between accounts published in 2015/16 and 2016/17. See also note 2. 
 
The use of agency staff is subject to considerable year-on-year variation, as shown in figure 11. 
Following a sustained period of growth in expenditure on agency staff from 2011/12 to 2015/16, 
expenditure in 2016/17 was lower than the previous two years. This fall in expenditure may in part 
reflect a shift away from agency staff and towards bank staff by NHS Trusts. We do not have specific 
figures for bank staff spend. However, the main difference between the value of ESR spend (used in 
our direct measure) and Labour spend in published accounts is the inclusion of bank staff spend in 
accounts data. The NHS pay review body 2018 reported a pay bill per FTE increase of 2.4% for staff 
recorded on ESR between 2015/16 and 2016/1726. The growth in total FTE staff in ESR from Table 39 
is 2.36%. Applying the wage growth from the pay review body report to the observed growth in FTEs 
ESR staff gives a growth in spend on staff of 4.8%.Table 45: Total NHS current expenditure (£000) 
Table 45 (below) indicates growth in staff spend of 5.4% from accounts figures which include bank 
staff. Therefore, the difference of 0.6% is likely to be due to increased numbers of bank staff and/or 
a larger increase in the unit cost of bank staff, which are not reported in the ESR data.  
                                                             
26 See Table 3.6, p50. 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/720320/NHSPRB_201
8_report_Web_Accessible.pdf 
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Figure 11: Trends in use of agency staff 
 
Table 45 presents current expenditures for the whole NHS. From 2013/14 onwards, we do not 
include spend for DH (now DHSC) administration. This is due to the restructuring of the NHS and 
changes to the DH (now DHSC) responsibilities. 
 
Table 45: Total NHS current expenditure (£000) 
Year NHS Staff Agency Materials Capital Prescribing 
Primary 
Care 
DH 
Admin 
TOTAL 
2004/05 31,334,252 1,557,282 8,757,990 5,115,514 8,094,175 9,569,836 278,000 64,707,050 
2005/06 33,926,746 1,459,936 10,271,344 5,839,664 8,013,483 11,162,141 262,000 70,935,314 
2006/07 35,177,509 1,185,244 11,378,727 6,568,363 8,250,324 11,209,422 229,000 73,998,589 
2007/08 36,561,167 1,207,654 13,036,200 7,784,592 8,303,501 11,697,639 226,000 78,816,753 
2008/09 39,264,185 1,895,423 13,991,803 7,426,031 8,376,264 12,074,672 242,958 83,271,336 
2009/10 42,104,673 2,302,578 14,911,074 7,635,390 8,621,421 12,683,418 241,608 88,500,162 
2010/11 43,513,839 2,127,889 16,077,609 8,025,361 8,880,735 12,962,081 212,245 91,799,759 
2011/12 43,360,622 1,872,598 17,221,673 8,265,079 8,777,965 13,250,874 453,000 93,201,811 
2011/12* 43,457,477 1,862,385 19,154,991 13,892,358 8,777,965 13,250,874 453,000 100,849,049 
2012/13* 43,654,591 2,345,552 21,442,537 14,273,017 8,397,492 13,419,803 457,000 103,989,992 
2013/14* 44,310,698 2,578,931 22,528,639 13,914,103 8,540,424 13,294,670 n/a 105,167,465 
2013/14**     8,703,170   105,330,221 
2014/15**1 45,562,935 3,333,806 23,582,829 13,323,481 8,942,734 13,460,552 n/a 108,206,337 
2015/16**2 46,787,408 3,702,409 25,604,358 13,899,138  9,288,425 13,759,292 n/a 113,041,030 
2015/16**3    13,632,724   n/a 112,774,617 
2016/17** 49,325,649 2,934,876 26,479,526 14,794,243 9,193,913 13,427,480 n/a 116,155,687 
*For NHS Trusts, data from prior to 2011/12 from Financial Returns and from 2011/12 onwards data from Financial Monitoring and 
Accounts. Agency costs, material and capital items are identified differently in each source. 
** In February 2017, NHS Digital released a new set of prescribing data to include previously omitted drug codes. The 2013/14 and 
2014/15 expenditure figure for prescribing are based on the new data. 
1 Figures differ from Castelli et al. (2018) due to including expenditure from two Trusts which were not part of previous equivalent figures.  
2 Figures differ from Castelli et al. (2018) due to including expenditure from two Trusts which were not part of previous equivalent figures. 
In addition, impairment is allocated to capital instead of materials. 
3 Figure for 2015/16 used to calculate growth between 2015/16 and 2016/17. This uses information for 2015/16 from the 2016/17 
ĂĐĐŽƵŶƚƐǁŚĞƌĞĂŶĂŵŝŶŐĐŽŶǀĞŶƚŝŽŶŚĂƐĐŚĂŶŐĞĚĂŶĚƚŚĞǀĂůƵĞŽĨ ?EĞƚŝŵƉĂŝƌŵĞŶƚƉƌŽƉĞƌƚǇƉůĂŶƚĂŶĚĞƋƵŝƉŵĞŶƚ ?ĨŽƌ ? ? ? ? ? ? ?ĚŝĨĨĞƌƐ
between accounts published in 2015/16 and 2016/17. See also note 2.  
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 Input growth 
Our measures of input growth are reported in Table 46. Both the mixed and indirect methods of 
calculating inputs are presented.  
 
For 2015/16  ? 2016/17 the mixed index suggests a growth rate of 0.64%, while the indirect index 
suggests an input growth rate of 1.47%. This implies that growth in Labour inputs between 2015/16 
and 2016/17 is greater if using expenditure data rather than ESR data. One explanation for this 
difference is the inclusion of expenditure on bank staff in the indirect measure of labour inputs, 
which is not included in the direct measure. 27 
 
Table 46: Input growth 
Years All NHS 
 Mixed Indirect 
2004/05  ? 2005/06 7.19% 7.10% 
2005/06  ? 2006/07 1.92% 1.36% 
2006/07  ? 2007/08 3.88% 3.70% 
2007/08  ? 2008/09 4.23% 4.24% 
2008/09  ? 2009/10 5.43% 5.83% 
2009/10  ? 2010/11 1.33% 0.80% 
2010/11  ? 2011/12 1.00% 0.75% 
2011/12  ? 2012/13 1.98% 2.63% 
2012/13  ? 2013/14 0.43% 0.55% 
2013/14  ? 2014/15 1.94% 1.52% 
2014/15  ? 2015/16§ 2.73% 3.18% 
2015/16  ? 2016/17 0.64% 1.47% 
§ Figures include two Trusts which were not included in the figures reported in Castelli et al. (2018). 
Table 47 presents contributions to Input growth, following the same approach as discussed in 
Section 2.7.1 on the contribution by NHS settings to NHS Output growth. The largest contribution to 
growth in inputs is from labour (42.47%), followed by materials (23.56%). This table also highlights 
that while the reduction in spend on agency is large relative to agency spend, the contribution of this 
to overall input growth is small at 2.58%. 
  
                                                             
27 The figures for 2014/15 and 2015/16 include the two Trusts that were missed out in Castelli et al. (2018). The 
corrected measures of input growth are higher than previously reported. Specifically, the mixed method 
indicates growth in inputs which is 0.14% higher at 2.73%. The indirect method indicates an increase in inputs 
growth by 0.36% at 3.18%. 
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Table 47: Contribution to Inputs Growth by type of input, 2016/17 
Setting Growth Setting 
specific 
growth 
index 
Value of 
Activity 
(15/16 
prices) 
Share of 
overall 
spend 
Contribution to 
growth 
      
Labour (Direct) 
(Labour (Indirect, excl 
agency staff)) 
2.36% 
(4.36%) 
102.36% 
(104.36%) 
46,787,408 41.49% 42.47% (43.30%) 
Agency -21.53% 78.47% 3,702,409 3.28% 2.58% 
Materials -0.62% 99.38% 25,604,358 22.70% 23.56% 
Capital 4.29% 104.29% 13,632,724 12.09% 12.61% 
Primary care -4.43% 95.57% 13,759,292 12.20% 12.61% 
Prescribing 6.44% 106.44% 9,288,425 8.24% 8.77% 
      
Total/ NHS Input 
growth rate 
  
112,774,617 
 
0.64% (1.47%) 
 
Table 48 presents expenditure and Laspeyres growth rates for each input type for 2013/14-14/15 to 
2014/15-15/16. The patterns of Laspeyres Input Growth over time indicate a high degree of volatility 
in the growth of individual categories, especially for Agency spend. There is no strong pattern of 
growth rates over time across different types of inputs based on these three points. The deflators 
used for each input category are also presented. The deflators used are discussed in more detail in 
Appendix D.1.  
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Table 48: Expenditure, Deflator and Input Growth rates by type of input 
Inputs 
 
Years 
 
2013/14-
2014/15 
2014/15-
2015/16 
2015/16-
2016/17 
 
    
Labour 
Expenditure 
growth 
2.10% 2.69% 5.43% 
Pay HCHS (ESR) 
Deflator 
0.30% 0.30% 1.01% 
Laspeyres Input 
Growth 
1.79% 2.38% 4.36% 
Agency 
Expenditure 
growth 
29.27% 11.06% -20.73% 
Pay Deflator 0.30% 0.30% 1.01% 
Laspeyres Input 
Growth 
28.88% 10.72% -21.53% 
Materials 
Expenditure 
growth 
4.05% 8.57% 3.42% 
Price Deflator 1.70% 2.70% 3.90% 
Laspeyres Input 
Growth 
2.28% 5.64% -0.62% 
Capital 
Expenditure 
growth 
-4.53% 4.32% 8.52% 
Price Deflator 1.70% 2.70% 3.90% 
Laspeyres Input 
Growth 
-6.15% 1.50% 4.29% 
Primary 
care 
Expenditure 
growth 
1.25% 2.22% -2.48% 
Pay and Price 
Deflator 
0.88% 1.32% 2.06% 
Laspeyres Input 
Growth 
0.35% 0.87% -4.50% 
Prescribing 
Expenditure 
growth 
2.75% 3.87% -1.02% 
Pharmaceutical 
Deflator 
-1.31% -0.07% -7.00% 
Laspeyres Input 
Growth 
4.10% 3.94% 6.44% 
 
  
Productivity of the English NHS: 2016/17 update  55 
 
4 Productivity growth 
Year-on-year productivity growth figures from 2004/05 to 2016/17 are provided in Table 49. These 
figures are constructed by comparing the quality-adjusted NHS output growth rate, as reported in 
the final column of Table 35, with the estimates of mixed and indirect input growth, as reported in 
Table 46.  
 
&ŝƌƐƚ ?ůĞƚ ?ƐŽďƐĞƌǀĞ the trend in the year-on-year growth of NHS output and NHS input separately, as 
depicted in Figure 12. Between 2015/16 and 2016/17 NHS output has increased, whilst NHS input 
(mixed) growth rate has decreased. This will result in a positive growth in NHS productivity, as 
reported in Table 49. In particular, NHS productivity is estimated to have increased by 2.86% based 
on the mixed method, and 2.01% based on the indirect method. 
 
 
Figure 12: Input and Output growth 
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Table 49: Quality-adjusted productivity growth year-on-year 
Years All NHS 
 Mixed Indirect 
2004/05  ? 2005/06 -0.07% 0.01% 
2005/06  ? 2006/07 4.50% 5.07% 
2006/07  ? 2007/08 -0.21% -0.04% 
2007/08  ? 2008/09 1.44% 1.43% 
2008/09  ? 2009/10 -1.25% -1.63% 
2009/10  ? 2010/11 3.21% 3.74% 
2010/11  ? 2011/12 2.13% 2.38% 
2011/12  ? 2012/13 0.36% -0.28% 
2012/13  ? 2013/14 2.20% 2.07% 
2013/14  ? 2014/15 0.53% 0.95% 
2014/15  ? 2015/1628 -0.15% -0.58% 
2015/16  ? 2016/17 2.86% 2.01% 
 
Finally, Figure 13 shows the trend in the NHS Output, Input and Productivity indices from the start of 
the most recent time series (2004/05). NHS Outputs and Inputs have both increased since 2004/05, 
with NHS Outputs increasing by about 60% over the whole period, and NHS inputs by just under 
38%. 
 
 
Figure 13: Trends in input, output and productivity indices 
                                                             
28 The Mixed and Indirect NHS Productivity growth rates for the years 2014/15  W 2015/16 have been updated to reflect the 
methodological change in assigning PROMs values to activity with a UZ01 code for hospital inpatients (see Section 2.2.2) , as 
well as the inclusion of two missing Hospital Trusts in the input expenditure (see Section 3.2.1). 
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The increasing productivity growth that we observe in the NHS over time is not observed in the rest 
of the economy. Productivity is measured somewhat differently according to the nature of the data 
available for each sector of the economy, but the measures are otherwise equivalent. The main 
measure produced by the Office of National Statistics is called Gross Value Added per hour worked, 
which is used to measure the contribution to the economy of each sector in the United Kingdom.  2930 
 
The rate of NHS productivity growth since 2004/05 compares favourably with that achieved by the 
economy as a whole. From 2004/05 total productivity growth was 16.53% for the NHS, compared to 
only 6.72% in the whole economy. This is shown in the graph below, with the NHS productivity 
growth index outpacing the economy as a whole through the entire period. The recession in 2008/09 
is reflected by the notable dip in the two series. Since then, NHS productivity has increased year-on-
year, whereas whole economy productivity has been falling or been stable over the same time 
period. The period between 2013/14  W 2015/16 is the only time after 2008/09 where the 
productivity for the whole economy grew at a faster rate than that for the NHS. Between 2015/16 
and 2016/17, NHS productivity growth abandoned a period of stagnation and outpaced again the 
productivity for the whole economy, respectively at 2.86% vs. 0.50%.  
 
 
Figure 14: Comparison of productivity indices: NHS vs. Whole Economy 
  
                                                             
29 http://www.ons.gov.uk/ons/guide-method/method-quality/specific/economy/national-accounts/gva/relationship-gva-
and-gdp/gross-value-added-and-gross-domestic-product.html (link to National Archives  W last accessed 31/01/2019) 
30http://www.ons.gov.uk/employmentandlabourmarket/peopleinwork/labourproductivity/datasets/labourproductivitytabl
es110andr1 (last accessed 31/01/2019) 
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5 Conclusions 
Total NHS productivity growth between 2015/16 and 2016/17 amounted to 2.86% according to our 
preferred mixed method, which corresponds to an average annual growth of 1.30% from 2004/05. 
 
Quality adjusted output growth between 2015/16 and 2016/17 amounted to 3.51% for the NHS as a 
whole, which is larger than the growth recorded between 2014/15 and 2015/16. Despite the 
increase over the last two financial years, this remains lower than the average over the whole period 
(4.03 %). Positive growth is observed in most settings, with the exception of Ophthalmology & 
Dentistry, which is mainly due to a decrease in dental services, Rehabilitation and Other NHS activity. 
Growth was substantial for the second consecutive year in the settings Outpatient, amounting to 
5.34%, and Community Prescribing, 6.44%. We observe also high growth in Chemo/Radiotherapy & 
High Cost Drugs and in Radiology, respectively equal to 8.39% and 6.77%. The former representing 
about 4.3% of the total value of NHS activity and the latter just over 1.2%. 
 
Quality of care is captured only for hospital inpatient activity by measuring changes in survival 
following hospital admission, health status, life expectancy and waiting times, and for primary care 
activity by changes in blood pressure monitoring of patients with either Coronary heart disease, 
Stroke or Hypertension. There were improvements in most of the quality measures for hospital 
inpatient activity except waiting times and health status. The quality of primary care has improved 
between 2015/16 and 2016/17 for all three conditions monitored, due mainly to higher QOF 
achievements for all three conditions. Overall, however, the net effect in the quality improvement is 
minimal between 2015/16 and 2016/17, adding about 0.16 percentage points to the cost-weighted 
output index.  
 
Our indirect measure of input growth indicates a growth of 1.47% between 2015/16 and 2016/17 
and our mixed measure (using the direct measure of labour) indicates growth of 0.64%. Our usual 
base case measure uses the mixed method, as it is generally recommended to use direct measures 
of input whenever possible. However, the Department of Health and Social Care has brought to our 
attention that Hospital Trusts have substantially decreased their use of agency staff (as reported in 
Section 3.3) and increased the use of bank staff in 2016/17. Bank staff are not captured by the ESR 
data. This may have artificially resulted in a smaller than expected growth in the use of labour 
inputs, which may explain the modest growth in the mixed input growth rate compared to the 
indirect input growth rate between 2015/16 and 2016/17. 
 
As in previous years, we also report a measure of Hospital Trusts only in Appendix E. NHS Trusts 
output growth is 3.60% and their mixed (indirect) input growth is 1.15% (2.35%) between 2015/16 
and 2016/17; thus leading to productivity growth of 2.42% (1.22%) between these two years.  
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Appendix A 
 Technical details 
In calculating productivity growth for the health care system, it is necessary to combine the 
multitude of outputs and inputs into single measures for both outputs and inputs. This requires the 
construction of an output growth index (ܺ) and an input growth index (ܼ), with total factor 
productivity growth  ?ܶܨ  ܲcalculated by comparing growth in outputs with growth in inputs such 
that:  
  ?ܶܨܲ ൌሾܺȀܼሿ           (E1) 
 
In order to estimate total factor productivity, it is necessary to correctly define and measure the 
output and input indices. 
 
Output growth 
Quantification of health care output is a challenge because patients have varied health care 
requirements and receive very different packages of care. To address this, it is necessary to classify 
patients into reasonably homogenous output groupings, such as Healthcare Resource Groups (HRGs) 
or Reference Cost (RC) categories. Furthermore, in order to aggregate these diverse outputs into a 
single index, some means of assessing their relative value is required. Usually prices are used to 
assess value, but prices are not available for the vast majority of NHS services for which people do 
not have to pay at point of use. In common with the treatment of other non-market sectors of the 
economy in the national accounts, costs are used to indicate the value of health services. Costs 
reflect producer rather than consumer valuations of outputs, but have the advantage of being 
readily available (Eurostat, 2001). 
 
ƐĐŽƐƚƐĂƌĞŶŽƚďĞůŝĞǀĞĚƚŽƚƌƵůǇƌĞĨůĞĐƚĐŽŶƐƵŵĞƌƐ ?ǀĂůƵĂƚŝŽŶƐ ?ƚŬŝŶƐŽŶƐƵŐŐĞƐƚƐƐƵƉƉůĞŵĞŶƚŝŶŐ
costs with information about the quality of non-market goods and services (Atkinson, 2010). One 
way of doing this is by adding a scalar to the output index that captures changes over time in 
different dimensions of quality (Castelli et al., 2007). Thus, following Castelli et al. (2007), the output 
growth index (in its Laspeyres form) can be calculated across two time periods as: 
 
    ܺሺ଴ǡ௧ሻ௖௤ ൌ  ? ௫ೕ೟௖ೕబቈೡೕబ೜ೕ೟೜ೕబ ቉಻ೕసభ ? ௫ೕబ௖ೕబ಻ೕసభ      (E2) 
 
We define ݔ௝  as the number of patients who have output type j, where jA? ? ?J; ௝ܿ௢  indicates the cost 
of output j; ݍ௝ represents a unit of quality for output j, and ݒ௝ is the value of this unit of quality; and t 
indicates time with 0 indicating the first period of the time series. Our measures of quality include 
inpatient and outpatient waiting times, health improvements (limited to four conditions), survival 
rates following hospitalisation, and blood pressure management in primary care.  
 
Input growth 
Turning to the input growth index (ܼ), inputs into the health care system consist of labour, material 
goods and capital. Growth in the use of these factors of production can be calculated directly or 
indirectly (OECD, 2001). A direct measure of input growth can be calculated when data on the 
volume and price of inputs are available. In its Laspeyres form, the input growth index can be 
calculated as: 
 ܼሺ଴ǡ௧ሻ஽ ൌ  ? ௭೙೟ఠ೙బ೙ಿసభ ? ௭೙బఠ೙బ೙ಿసభ        (E3) 
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Where ݖ௡௧  is the volume of input of type n at time t and ߱௡௧  is the price of input type n at time t.  
 
However, data about the volume of inputs are rarely available. It is, therefore, common practice to 
calculate input growth using expenditure data. Changes in expenditure are driven by both changes in 
the volume of resource use and in prices. Hence to isolate the volume effect, it is necessary to wash 
ŽƵƚƉƌŝĐĞĐŚĂŶŐĞƐďǇĐŽŶǀĞƌƚŝŶŐ ‘ĐƵƌƌĞŶƚ ?ŵŽŶĞƚĂƌǇǀĂůƵĞƐŝŶƚŽ ‘ĐŽŶƐƚĂŶƚ ?ĞǆƉĞŶĚŝƚƵƌĞƵƐŝŶŐĂ
deflator ߨ௡௧ . This deflator reflects the underlying trend in prices for the input in question, such that ߱௡௧ାଵ ൌ ߨ௡௧߱௡௧ .  
 
If expenditure data and deflators are available, the input growth index can be specified as: 
 ܼሺ଴ǡ௧ሻூ௡ௗ ൌ  ? గ೙೟ா೙೟೙ಿసభ ? ா೙బ೙ಿసభ ൌ  ? ௭೙೟గ೙೟ఠ೙೟೙ಿసభ ? ௭೙బఠ೙బ೙ಿసభ ൌ  ? ௭೙೟ఠ೙బ೙ಿసభ ? ௭೙బఠ೙బ೙ಿసభ ൌ ܼሺ଴ǡ௧ሻ஽                   (E4) 
 
As shown, this is equivalent to using volume data, provided that deflators capture correctly the 
trend in prices for each input in question. 
 
Productivity growth 
The above equations show output or input growth over two periods from a base (0) to a current 
period (t). Usually, there is interest in assessing productivity growth over longer periods of time. We 
do this by means of a chained index that involves updating weights in every period, thereby making 
it possible to account for ongoing changes in the composition of the outputs and inputs being 
measured (Diewert et al., 2010). 
 
Using the Laspeyres output index as defined in eq. (E2), a chained output index takes the following 
form: 
 ܺሺ଴ǡ்ሻ௖௤ ൌ  ? ௫ೕ೟௖ೕబቈೡೕబ೜ೕ೟೜ೕబ ቉಻ೕసభ ? ௫ೕబ௖ೕబ಻ೕసభ ൈ   ? ௫ೕ೟శభ௖ೕ೟ቈೡೕ೟೜ೕ೟శభ೜ೕ೟ ቉಻ೕసభ  ? ௫ೕ೟௖ೕ೟಻ೕసభ ൈ ? ? ?ൈ  ? ௫ೕ೅௖ೕ೅షభቈೡೕ೅೜ೕ೅೜ೕ೅షభ ቉಻ೕసభ ? ௫ೕ೅షభ௖ೕ೅షభ಻ೕసభ    (E5) 
 
This can be simplified as: 
 ܺሺ଴ǡ்ሻ௖ǡ௤ ൌ ܺሺ଴ǡ௧ሻ௖ǡ௤ ൈ ܺሺ௧ǡ௧ାଵሻ௖ǡ௤ ൈ ? ? ?ൈ ܺሺ்ିଵǡ்ሻ௖ǡ௤          (E6) 
 
where each link is represented by eq. (E2) for the relevant two consecutive years. An analogous 
construction applies to the chained input index. 
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Appendix B 
 Independent sector providers (non-NHS bodies): output, input and sensitivity 
analysis, 2015/16  ? 2016/17 
In 2016/17, the Reference Cost data collection continues to include independent sector providers 
(non-NHS bodies). The availability of the total volume and unit cost of activity sub-contracted to the 
independent sector allowed us to keep track of the output growth in these providers. However, we 
only explore activity delivered by non-NHS providers as a sensitivity analysis and do not include 
them in the measure of NHS output and productivity growth. The total volume of activity has shown 
a relevant increase, as they are almost doubled with respect to 2015/16, as shown in Table B1. From 
this table we excluded the inpatient activity, which are covered in the national NHS output series 
based on the HES APC database.  
 
Table B1: Volume and value of activity provided by non-NHS bodies, 2015/16 and 2016/17 
Year Volume of activity Value of activity (current) Value of activity (constant costs  ? 
base year, with correction for high 
and low cost outliers) 
2015/16 4,487,986 169,219,627 81,813,032 
2016/17 8,761,439 206,282,510 222,316,220 
 
The increase in volume of activity is mostly due to an increase in Diagnostic tests and, in particular, it 
is driven by two types of tests, namely clinical biochemistry and haematology. Given the fact that the 
same remarkable increase is reported in the Reference Cost for NHS providers, we hypothesise that 
the increase might be due to an attempt at reducing the number of unnecessary hospitalisations.  
 
In 2016/17 there are less categories with respect to 2015/16. In particular, there are not any activity 
registered for ambulance and rehabilitation services (as reported in Table B1), where the setting 
Ambulance and Emergency (A&E) just includes emergency setting activity and categories.  
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Table B2: Health care settings for which non-NHS bodies provided activity in 2015/16 and 2016/17 
Year Nr of Categories 
NHS settings 2015/16 2016/17 
A&E Services 13 25 
Chemo/Radiotherapy & High Cost Drugs 27 33 
Community Care 31 38 
Diagnostic Tests 7 10 
Community Mental Health 11 10 
Other 35 5 
Outpatient 316 459 
Radiology 72 95 
Rehabilitation 1 0 
Renal Dialysis 14 14 
Specialist Services 16 16 
Total 543 705 
 
In general, as shown in Table B2, the number of categories in 2016/17 notably increased, but setting 
specific totals are not directly comparable across the two years. For example, the number of 
categories reported under Specialist Services appears to be the same in 2016/17 and in 2015/16, but 
the type of categories are not necessarily the same. In fact, four new categories, neuroscience adult 
patient, thoracic surgical adult, burns and plastic surgery and renal adult patient, were reported in 
2016/17.  
Similarly to the quality checks performed for the Reference Cost data for NHS Trust and NHS 
Foundation Trusts, we also carried out quality checks for non-E,^ƉƌŽǀŝĚĞƌƐ ?ZĚĂƚĂ. We saw that 
there were no activities involved in large changes, both in terms of volume (>500,000 units) or value 
(> £25,000,000) among the two financial years analysed. We report the results of this check in Table 
B3, where the first activity registered a large change in the total value with respect to 2015/16 and 
this large change was driven by a large increase in the volume of activity while the current cost was 
dramatically lower. The last two rows in the table report the activities recording a large change in 
volume and, as mentioned before, they belong to the setting of ? Diagnostic test ?. 
Table B3: Large Changes in Value and Volume, between 2015/16 and 2016/17 
Setting Activity Volume of 
activity in 
2015/16 
Volume of 
activity in 
2016/17 
2015/16 
Unit 
Cost (£) 
2016/17 
Unit 
Cost (£) 
Difference 
Community 
care 
District nurse 
adult, face to face 
6,995 316,027 371 45 £103,029,186 
Diagnostic test Clinical 
Biochemistry 
2,457,197 5,118,763 1 1 £2,661,566 
Diagnostic test Haematology 438,089 1,074,410 2 2 £636,321 
 
The growth in the total amount of activity sub-contracted to non-NHS bodies between 2015/16 and 
2016/17 is given by the ratio between the value of activity in constant terms for 2016/17 and value 
of activity in constant terms for 2015/16 (see Table B1). Between 2015/16 and 2016/17 this is equal 
to 46%. 
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Purchases for health care services from non-NHS bodies are already accounted for in the national 
NHS input series (see Table 43 of this report). Table B4 summarises the value of these purchases by 
type of NHS Trusts for 2015/16 and 2016/17 respectively. 
Table B4: Purchases of health care services from non-NHS bodies (£000), 2015/16 and 2016/17  
Year Total value of purchases of health care services from non-NHS bodies (£000) 
 NHS Trust NHS Foundation Trusts Total 
2015/16 303,148 643,688 946,836 
2016/17 321,738 754,176 1,075,914 
 
Finally, we conduct a sensitivity analysis including NHS activity provided by non-NHS providers in the 
overall NHS output measure, and calculate the resulting NHS productivity growth measures. Table 
B5 reports the NHS output, input and productivity growth rates for the whole NHS, and for the 
whole NHS including activity contracted out to independent sector providers, whilst Table B6 
restricts the analysis to outputs provided by NHS Trusts and non-NHS bodies only. 
 
Table B5: NHS output, input and productivity growth rates, 2015/16  ? 2016/17, NHS overall 
Year  Output Input Productivity 
2015/16 
 ? 
2016/17 
 Indirect 
NHS Overall 3.51% 
1.47% 
2.01% 
NHS Overall, incl. non-NHS bodies 3.57% 2.07% 
    
 Mixed 
NHS Overall 3.51% 
0.64% 
2.86% 
NHS Overall, incl. non-NHS bodies 3.57% 2.91% 
 
Table B6: NHS output, input and productivity growth rates, 2015/16  ? 2016/17, Trusts and non-NHS bodies 
only 
Year  Output Input Productivity 
2015/16 
 ? 
2016/17 
 Indirect 
Trusts only 3.60% 
2.35% 
1.22% 
Trusts only and non-NHS bodies 3.85% 1.47% 
    
 Mixed 
Trusts only 3.60% 
1.15% 
2.42% 
Trusts only and non-NHS bodies 3.85% 2.68% 
 
We find that including services sub-contracted to non-NHS bodies increases the NHS productivity 
growth rate by 0.05 percentage points in the mixed method. Restricting the analysis to Trusts only, 
we find that including services delivered by non-NHS bodies increases the NHS Trusts only 
productivity growth rate by 0.26 percentage points (mixed method). 
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Appendix C 
 Summary Statistics of Reference Costs data by broad service setting 
Table C1: Reference Cost settings, 2012/13  ? 2013/14 
Setting 2012/13 2013/14 
  Nr Cat. Activity Cost (£) Nr Cat. Activity Cost (£) 
A&E and Ambulance Services 89 34,952,786 3,692,014,018 90 35,051,392 3,923,106,579 
Chemo/Radiotherapy & High Cost 
Drugs 
317 6,754,603 2,652,051,626 323 6,988,301 2,915,174,231 
Community Care 149 79,709,044 4,139,765,181 174 85,975,592 4,864,684,367 
Diagnostic Tests 64 342,280,609 941,490,357 72 368,505,992 964,981,062 
Community Mental Health 117 260,266,214 6,311,927,307 124 259,659,214 6,410,525,825 
Outpatient 6,979 77,222,725 8,546,218,360 8,055 81,699,802 9,275,173,143 
Radiology 5,047 9,381,616 859,058,674 136 9,709,456 904,796,391 
Rehabilitation 119 2,715,650 817,792,033 113 3,002,512 893,588,640 
Renal Dialysis 40 4,135,914 528,076,698 40 4,079,238 533,459,915 
Specialist Services 86 4,359,263 2,927,444,066 145 4,699,893 3,030,502,560 
Other 3,099 4,763,955 354,760,843 937 3,927,412 309,107,379 
 
Table C2: Reference Cost settings, 2014/15  ? 2015/16 
Setting 2014/15 2015/16 
 Nr Cat. Activity Cost (£) Nr Cat. Activity Cost (£) 
A&E and Ambulance Services 89 36,551,479 4,201,423,614 92 37,792,911 4,454,964,482 
Chemo/Radiotherapy & High Cost 
Drugs 
344 7,567,487 3,351,048,218 340 6,283,287 3,697,193,821 
Community Care 180 85,733,534 5,052,768,659 184 86,767,072 5,171,028,803 
Diagnostic Tests 82 363,656,649 994,023,634 81 367,378,910 984,870,571 
Community Mental Health 130 259,036,112 6,489,414,327 125 253,275,018 6,309,945,016 
Outpatient 9,465 83,856,229 9,815,241,661 9,616 85,394,479 10,221,877,406 
Radiology 258 9,866,952 944,288,512 267 10,755,438 1,048,586,605 
Rehabilitation 121 3,008,889 954,413,054 99 2,985,717 990,145,041 
Renal Dialysis 39 4,070,447 533,927,599 37 4,157,008 556,027,298 
Specialist Services 145 4,967,499 3,252,277,420 143 5,162,337 3,402,452,724 
Other 1,119 3,407,664 287,913,867 1,130 3,990,126 319,906,305 
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Appendix D 
 Deflators 
We use various deflators to adjust our expenditure series, as shown in Table D1. We apply the 
Hospital and Community Health Services (HCHS) prices deflator for materials and capital. For labour 
and prescribing expenditure, we construct our own deflators using ESR and Prescription Cost 
Analysis data respectively. Up to 2015/16 we used a pay and prices deflator for primary care 
expenditure. For the 2015/16-2016/17 link, this deflator is not available. Therefore, we construct a 
pay and price deflator using the following formula 0.1 + 0.4*(ESR deflator) + 0.4*(HCHS). This 
formulation matches the one used previously by the DH to construct pay and price deflators from 
HSCI and a price deflator which draws in ESR data.  
 
Several other potential replacements for the pay and price deflator were tested and it was found 
that the impact of different approaches on the measures of input and productivity growth were 
modest. If it is assumed that the deflator was the same as the previous year, this indicates a value of 
1.32% for the pay and price deflator, 0.73% for Input growth and 2.77% for productivity growth. That 
is, an increase in input growth by 0.09% and a decrease in productivity growth by 0.09% compared 
to our preferred deflator. We also considered alternative weights for the pay and price deflators, 
estimated by running an ordinary least squares model of pay and price deflators from recent years 
and including the pay deflator estimated by ESR and prices deflator from DHSC as independent 
variables. This approach indicated a value for the pay and price deflator of 2.17%. Applying this value 
of the pay and price deflator implies input growth of 0.63% and productivity growth of 2.87%. In 
order for productivity growth to differ from our preferred measure by 0.1%, holding all else equal, 
the pay and price deflator would need to take a value outside the range of 1.31% and 2.88%. 
 
Table D1: Deflators 
 Pay HCHS (ESR) 
deflator 
Prices deflator Pay and Prices 
deflator 
Pharmaceuticals 
2004/05 - 2005/06 4.7% 1.9% 3.7% -9.9% 
2005/06 - 2006/07 -1.1% 3.0% 3.7% -3.4% 
2006/07 - 2007/08 3.5% 1.8% 2.9% -6.2% 
2007/08 - 2008/09 3.0% (3.33%) 5.2% 3.9% -5.2% 
2008/09 - 2009/10 1.8% (2.38%) -1.3% 0.6% -3.7% 
2009/10 - 2010/11 3.1% (1.19%) 2.8% 3.0% -1.7% 
2010/11 - 2011/12 0.9% (2.8%) 4.1% 2.1% -4.4% 
2011/12 - 2012/13 0.9% (0.8%) 3.1% 1.7% -7.2% 
2012/13 - 2013/14 0.7% (0.5%) 1.8% 1.1% -1.5% 
2013/14 - 2014/15 0.3% (0.5%) 1.7% 0.9% -1.31% 
2014/15 - 2015/16 0.3% (1.9%) 2.70% 1.32% -0.07% 
2015/16 - 2016/17 1.0% 3.90% 2.07% -7.00% 
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Appendix E 
 Trusts only productivity measures 
While the main body of our text focuses on a full-NHS measure of productivity, we also produce 
estimates of Trusts-only productivity changes, and the components thereof. 
 
As shown in Table E1, when we look at the activity performed by Trusts only, the quality-adjusted 
output index rises to 3.60%.  
 
Similarly, we can also produce a Trusts-only input index. As shown in Table E1, the input index is 
lower when taking only Trusts into account, with a mixed index suggesting growth of 1.15% and 
indirect index growth of 2.35%. As discussed for the main analysis, the difference between inputs 
growth indices produced by the mixed and indirect methods can be partially explained by an 
increase of use of bank staff to deal with instances of increased patient demands.  
 
Table E1: Input, output and productivity growth, Trusts only 
Years Output 
Growth 
 Input 
growth 
Productivity 
growth 
2013/14  ? 2014/15 2.86% Mixed 2.27% 0.58% 
Indirect 1.46% 1.39% 
2014/15  ? 2015/16* 3.31% Mixed 2.59% 0.70% 
Indirect 3.12% 0.19% 
2015/16  ? 2016/17 3.60% Mixed 1.15% 2.42% 
Indirect 2.35% 1.22% 
* The figures reflect changes in both NHS outputs and NHS Inputs following the update of the methods used to assign 
PROM values to activity with a UZ01 code for hospital inpatients (see Section 2.2.2) , as well as the inclusion of two missing 
Hospital Trusts in the input expenditure (see Section 3.2.1). 
 
Using this information we can produce Trust-only productivity growth figures for 2015/16 and 
2016/17, estimated as 2.42% for the mixed measure and at 1.22% for the indirect measure.  
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Appendix F 
 Changes to PROMs code 
Patient Reported Outcome Measures (PROMs) are one of the four elements that make up our 
quality adjustment measure. PROMs are available for four conditions: unilateral hip and knee 
replacement, varicose vein surgery and groin hernia repair. For conditions with PROM information 
we apply a value of the ratio of EQ5D values before and after treatment given by each patient. For 
conditions not present in PROMs data, we apply a constant value of 0.4 for non-electives and 0.8 for 
elective care HRGs. 
 
The PROMs dataset is made up of elective and day case patients with a valid PROMs record and 
includes a variable that indicates the HRG associated with each episode of care. Some of these 
records have the HRG error code of UZ01Z. The PROMs-based quality-adjustment code included a 
cut-off of at least 100 observations per PROMs-HRG, with the aims of excluding those HRGs with a 
low number of records. The PROMs dataset is then mapped to the HES dataset at the HRG level. 
Thus, if a particular PROMs-HRG has less than 100 observations in the PROMs dataset, this HRG will 
not be mapped to the HES Admitted Patient Care (APC) dataset. Therefore, these HRGs will be 
assigned the constant average value of 0.8 when they appear in the HES APC dataset. 
 
In the previous two financial years, the number of patient records with a UZ codes in the HES APC 
dataset experienced a large increase, which was also reflected in an increase of records with UZ 
codes in the PROMs dataset. For example, in 2015/16 the PROMs dataset had over 1,000 patient 
records with a UZ HRG code, whilst the number was only 87 in 2016/17. As a result, all observations 
with a UZ HRG code in the 2016/17 HES APC dataset were assigned the constant value 0.8 whilst 
those from 2015/16 were assigned the average ratio from PROMs data which was 0.31.  
 
The problem is that patients with a UZ HRG code within the PROMs dataset are only a very small 
sub-sample of all patients with a UZ HRG code in the HES APC dataset and as such these four 
conditions cannot be considered a representative sample of all UZ codes in the HES APC dataset. 
Therefore, by assigning the average PROM ratios to all UZ codes, we run the risk of 
underestimating/overestimating the quality adjustment of these UZ codes. Following our previous 
example, the increase of the ratio from 0.31 to 0.8 would have had an overestimated negative 
impact on the overall quality adjustment of hospital inpatient activity. 
 
We have thus decided to correct our methodology and not to assign PROMs value to CIPS with a UZ 
HRG code.  
 
Further, we found an additional error in the SAS code for PROMs, which was assigning actual PROMs 
values also to non-elective activity for the HRGs associated with the four PROM conditions as well as 
to the UZ HRG code. As PROMs are only recorded for elective surgery, we have reverted to assigning 
them the constant value 0.4.  
 
The two issues with the PROMs code affected our estimation of the hospital inpatient quality 
adjusted output growth rates for the financial years 2014/15 and 2015/16.  
 
Table F2 shows a comparison of the published inpatient growth rates and the resulting growth rates 
after the corrections of the SAS code and the change in methodology. For the link 2014/15 - 2015/16 
the effect is almost negligible because the UZ HRG codes in the PROMs dataset had a frequency 
greater than 100 in both financial years. Therefore, UZ codes passed the cut-off in both years. Those 
values were k =0.33906 and k =0.31290 respectively for 2014/15 and 2015/16, leading to a small 
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overestimation of the overall quality adjusted hospital inpatient growth rates. Please see Table F2   
below for further details on the corrections for the two issues. 
 
Table F2: Assessment of the effect of the changes in PROMS methodology on inpatient output growth 
ALL HES (Including 
Mental Health) 
Published Output 
Growth Figures (CHE RP 
152) 
1st Correction Assigning 
PROMS ratios only to 
PROMs Elective activity 
2nd Correction 
Assigning PROMs only 
to Electives and 
assigning UZ HRG code a 
constant K value (0.8 
(elective and day 
cases)/04(non-elective)) 
Cost-Adjusted Growth 
Rate 
3.389% 
Quality-Adjusted 
Growth Rate 
5.079% 5.005% 4.922% 
 
